1
|
Aboulfidaa N, Cliquet F, Robardet E, Darkaoui S, Wasniewski M, Kaiser C, Bobe K, Vos A, Fihri OF. Evaluation of Bait Acceptance and Immune Response in Local Dogs during an Oral Rabies Vaccination Field Study in Morocco. Trop Med Infect Dis 2024; 9:142. [PMID: 39058184 PMCID: PMC11281351 DOI: 10.3390/tropicalmed9070142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2024] [Revised: 05/20/2024] [Accepted: 05/21/2024] [Indexed: 07/28/2024] Open
Abstract
The objective of this study was to evaluate the bait preference of three selected bait types by local dogs and the induced immunogenicity of the oral rabies vaccine strain SPBN GASGAS in Morocco. The vaccine strain, combined with different bait types, has been tested in many different settings, but not yet in northern Africa. Overall, bait consumption and preference were similar in other studies using the same materials (bait type and sachet). The intestine bait had the highest acceptance rate (97.6%, 95%CI: 87.4-99.9), followed by the egg bait (83.0%, 95%CI: 69.2-92.4). Only 52% (95%CI: 37.4-66.3) of the dogs showed an interest in the fish meal bait. However, considering the successful release of the contents of the sachet (blue-dyed water) into the oral cavity, the egg bait (65.7%, 95%CI: 47.8-80.9) scored better than the intestine bait (51.7%, 95%CI: 32.5-70.6). The dogs selected for the immunogenicity study were offered the egg bait containing a sachet filled with SPBN GASGAS (3.0 mL, 107.5 FFU/mL) or were given the same dose by direct oral administration (d.o.a.). In addition, several dogs were vaccinated by the parenteral route (s.c.) using a commercially available inactivated rabies vaccine. Unfortunately, due to the COVID-19 pandemic and subsequent travel restrictions, it was not possible to collect blood samples directly after vaccination. The blood samples were collected pre-vaccination and on five occasions between 450 and 1088 days post vaccination. The seroconversion rate, as determined for rabies-virus-neutralizing antibodies by the FAVN test, was significantly lower than that found for binding antibodies, as determined by ELISA, for all blood samples collected post vaccination. No treatment effect (bait, d.o.a., s.c.) could be seen in the seroconversion rate. At 15 months post vaccination, 84.2% of the dogs offered vaccine bait still tested sero-positive in ELISA. Only after 3 years was a clear drop in the seroconversion rate observed in all three treatment groups. This study confirms the long-term immunogenicity of the oral rabies vaccine SPBN GASGAS in dogs under field conditions.
Collapse
Affiliation(s)
- Nadia Aboulfidaa
- Division of Pharmacy and Veterinary Inputs, National Food Safety Office, Rabat BP 4509, Morocco; (N.A.); (S.D.)
| | - Florence Cliquet
- ANSES—Nancy Laboratory for Rabies and Wildlife, French Agency for Food, Environmental and Occupational Health & Safety, European Union Reference Laboratory for Rabies, WHO Collaborating Centre for Research and Management in Zoonoses Control, WOAH Reference Laboratory for Rabies, Technopôle Agricole et Vétérinaire de Pixérécourt, 54220 Malzéville, France; (F.C.); (E.R.); (M.W.)
| | - Emmanuelle Robardet
- ANSES—Nancy Laboratory for Rabies and Wildlife, French Agency for Food, Environmental and Occupational Health & Safety, European Union Reference Laboratory for Rabies, WHO Collaborating Centre for Research and Management in Zoonoses Control, WOAH Reference Laboratory for Rabies, Technopôle Agricole et Vétérinaire de Pixérécourt, 54220 Malzéville, France; (F.C.); (E.R.); (M.W.)
| | - Sami Darkaoui
- Division of Pharmacy and Veterinary Inputs, National Food Safety Office, Rabat BP 4509, Morocco; (N.A.); (S.D.)
| | - Marine Wasniewski
- ANSES—Nancy Laboratory for Rabies and Wildlife, French Agency for Food, Environmental and Occupational Health & Safety, European Union Reference Laboratory for Rabies, WHO Collaborating Centre for Research and Management in Zoonoses Control, WOAH Reference Laboratory for Rabies, Technopôle Agricole et Vétérinaire de Pixérécourt, 54220 Malzéville, France; (F.C.); (E.R.); (M.W.)
| | - Christian Kaiser
- TEW Servicegesellschaft GmbH, Am Pharmapark (formerly at Ceva Innovation Center), 06861 Dessau-Rosslau, Germany;
| | - Katharina Bobe
- Ceva Innovation Center GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany;
| | - Ad Vos
- Ceva Innovation Center GmbH, Am Pharmapark, 06861 Dessau-Rosslau, Germany;
| | - Ouafaa Fassi Fihri
- Department of Pathology and Veterinary Public Health, Agronomic and Veterinary Institute Hassan II, Rabat BP 6202, Morocco;
| |
Collapse
|
2
|
Robardet E, Zdravkova A, Ilieva D, Hakmann E, Georgopoulou I, Tasioudi K, Nokireki T, Isomursu M, Jankovic IL, Lojkic I, Serzants M, Zommere Z, Masiulis M, Jaceviciene I, Vuta V, Wasniewski M, Dilaveris D. Retrospective analysis of sero-prevalence and bait uptake estimations in foxes after oral rabies vaccination programmes at European level: Lessons learned and paths forward. Vet Microbiol 2024; 288:109917. [PMID: 38039917 DOI: 10.1016/j.vetmic.2023.109917] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 11/09/2023] [Accepted: 11/17/2023] [Indexed: 12/03/2023]
Abstract
Rabies caused by the Classical Rabies Virus (Lyssavirus rabies abbreviated RABV) in the European Union has been close to elimination mainly thanks to Oral Rabies Vaccination (ORV) campaigns targeting wildlife (primarily red foxes). ORV programmes co-financed by the European Commission include a monitoring-component to assess the effectiveness of the ORV campaigns at national level. This assessment is performed by a random collection of red foxes in the vaccinated areas with control of antibodies presence by serological analysis and control of bait uptake by detection of biomarkers (tetracycline incorporated into the baits) in the bones and teeth. ORV programmes aim to a vaccine coverage high enough to immunize (ideally) 70 % of the reservoir population to control the spread of the disease. European Union (EU) programmes that led to almost elimination of rabies on the territory have been traditionally found to have a bait uptake average of 70 % (EU countries; 2010-2020 period) while the seroconversion data showed an average level of 40 % (EU countries; 2010-2020 period). To better understand variations of these indicators, a study was been set up to evaluate the impact of several variables (linked to the vaccination programme itself and linked to environmental conditions) on the bait uptake and the seroconversion rate. Thus, pooling data from several countries provides more powerful statistics and the highest probability of detecting trends. Results of this study advocate the use of a single serological test across the EU since data variation due to the type of test used was higher than variations due to field factors, making the interpretation of monitoring results at EU level challenging. In addition, the results indicates a negative correlation between bait uptake and maximum temperatures reached during ORV campaigns questioning the potential impact of climatic change and associated increase of temperatures on the ORV programmes efficiency. Several hypotheses requesting additional investigation are drawn and discussed in this paper.
Collapse
Affiliation(s)
- Emmanuelle Robardet
- Anses, Nancy Laboratory for Rabies and Wildlife, EURL for Rabies, Bâtiment H, Technopôle Agricole et Vétérinaire, CS 40 009, 54220 Malzéville Cedex, France.
| | - Anna Zdravkova
- Bulgarian Food Safety Agency, 15 Pencho Slaveykov Blvd., Sofia 1606, Bulgaria
| | - Darinka Ilieva
- National Diagnostic and Research Veterinary Institute, 15 Pencho Slaveykov Blvd., Sofia 1606, Bulgaria
| | - Enel Hakmann
- Veterinary and Food Board, Teaduse 2, Saku, Harjumaa 7550 Väike-Paala 3, Tallinn 11415, Estonia
| | - Ioanna Georgopoulou
- Department of Zoonoses, Animal Health Directorate, Directorate General of Veterinary Medicine, Ministry of Rural Development and Food, 46, Veranzerou str, PC 104 38 Athens, Greece
| | - Konstantia Tasioudi
- Department of Molecular Diagnostics, FMD, Virological, Ricketsial and Exotic diseases, Athens Veterinary Centre, Ministry of Rural Development and Food, 25, Neapoleos str, PC 15341, Agia Paraskevi, Athens, Greece
| | - Tiina Nokireki
- Finnish Food Authority, Mustialankatu 3, 00790 Helsinki, Finland; Finnish Food Authority, Elektroniikkatie 3, 90590 Oulu, Finland
| | - Marja Isomursu
- Finnish Food Authority, Mustialankatu 3, 00790 Helsinki, Finland; Finnish Food Authority, Elektroniikkatie 3, 90590 Oulu, Finland
| | - Ivana Lohman Jankovic
- Ministry of Agriculture, Veterinary and Food Safety Directorate, Savska cesta 143, 10000 Zagreb, Croatia
| | - Ivana Lojkic
- Croatian Veterinary Institute, Savska cesta 143, 10000 Zagreb, Croatia
| | - Martins Serzants
- Food and Veterinary Service, Peldu street 30, Riga LV-1050, Latvia
| | - Zanete Zommere
- Institute of Food Safety, Animal Health and Environment "BIOR", Lejupes iela 3, Riga LV-1076, Latvia
| | - Marius Masiulis
- State Food and Veterinary Service, Siesiku str., 19 07170 Vilnius, Lithuania
| | - Ingrida Jaceviciene
- National Food and Veterinary Risk Assessment Institute, J. Kairiukscio str. 10, LT-08409 Vilnius, Lithuania
| | - Vlad Vuta
- Institute for Diagnosis and Animal Health, str dr staicovici nr, 63, 050557 Bucharest, Romania
| | - Marine Wasniewski
- Anses, Nancy Laboratory for Rabies and Wildlife, EURL for Rabies, Bâtiment H, Technopôle Agricole et Vétérinaire, CS 40 009, 54220 Malzéville Cedex, France
| | - Dimitrios Dilaveris
- European Commission, Directorate-General for Health and Food Safety, B-1049 Brussels, Belgium
| |
Collapse
|
3
|
Lugelo A, Hampson K, McElhinney LM, Lankester F. Evaluation of an iELISA for detection and quantification of rabies antibodies in domestic dog sera. Vaccine 2023; 41:6565-6571. [PMID: 37716829 DOI: 10.1016/j.vaccine.2023.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2023] [Revised: 09/02/2023] [Accepted: 09/02/2023] [Indexed: 09/18/2023]
Abstract
Many rabies endemic-countries have recognized rabies as a public health problem that can be eliminated. As a result, some countries have started implementing small-scale vaccination programs with the aim of scaling them up. Post-vaccination serological monitoring is crucial to assess the efficacy of these programs. The recommended serological tests, the rapid fluorescent focus inhibition test, and the fluorescent antibody virus neutralization (FAVN) are accurate; however, the procedures require considerable expertise and must be carried out in high containment facilities, which are often not available in rabies endemic countries. Given these constraints, enzyme linked immunosorbent assays (ELISAs) have been considered as alternative methods to neutralization tests. This is the first study to evaluate, under field conditions, the performance of the commercial rabies indirect-ELISA (iELISA), the PlateliaTM Rabies II kit ad usum Veterinarium kit, using sera from domestic dogs. Serum samples were collected from two groups of community dogs in northern Tanzania: i) dogs with no history of vaccination against rabies (n = 100) and ii) dogs vaccinated with the Nobivac Canine Rabies® vaccine (n = 101) four weeks previously. When compared to the gold standard FAVN test, the iELISA was found to be 99% specific and 98% sensitive and there was a significant correlation between the two tests (p < 0.001, r = 0.92). Given these findings, we conclude that the PlateliaTM Rabies II kit ad usum Veterinarium can be considered a valuable tool for the rapid assessment of vaccination status of animals in vaccination programs.
Collapse
Affiliation(s)
- Ahmed Lugelo
- Global Animal Health Tanzania, Arusha, Tanzania; Boyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Glasgow G12 8QQ, UK.
| | - Katie Hampson
- Boyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Glasgow G12 8QQ, UK
| | - Lorraine M McElhinney
- Viral Zoonoses Group, Animal and Plant Health Agency (APHA), Weybridge, New Haw, Addlestone, Surrey KT15 3NB, UK
| | - Felix Lankester
- Global Animal Health Tanzania, Arusha, Tanzania; Boyd Orr Centre for Population and Ecosystem Health, School of Biodiversity, One Health and Veterinary Medicine, University of Glasgow, Glasgow G12 8QQ, UK; Paul G. Allen School for Global Animal Health, Washington State University, Pullman, WA 99164, USA.
| |
Collapse
|
4
|
Megawati Saputra IL, Suwarno S, Husein WF, Suseno PP, Prayoga IMA, Vos A, Arthawan IM, Schoonman L, Weaver J, Zainuddin N. Immunogenicity of Oral Rabies Vaccine Strain SPBN GASGAS in Local Dogs in Bali, Indonesia. Viruses 2023; 15:1405. [PMID: 37376704 DOI: 10.3390/v15061405] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Revised: 06/14/2023] [Accepted: 06/16/2023] [Indexed: 06/29/2023] Open
Abstract
Dog-mediated rabies is endemic in much of Indonesia, including Bali. Most dogs in Bali are free-roaming and often inaccessible for parenteral vaccination without special effort. Oral rabies vaccination (ORV) is considered a promising alternative to increase vaccination coverage in these dogs. This study assessed immunogenicity in local dogs in Bali after oral administration of the highly attenuated third-generation rabies virus vaccine strain SPBN GASGAS. Dogs received the oral rabies vaccine either directly or by being offered an egg-flavored bait that contained a vaccine-loaded sachet. The humoral immune response was then compared with two further groups of dogs: a group that received a parenteral inactivated rabies vaccine and an unvaccinated control group. The animals were bled prior to vaccination and between 27 and 32 days after vaccination. The blood samples were tested for the presence of virus-binding antibodies using ELISA. The seroconversion rate in the three groups of vaccinated dogs did not differ significantly: bait: 88.9%; direct-oral: 94.1%; parenteral: 90.9%; control: 0%. There was no significant quantitative difference in the level of antibodies between orally and parenterally vaccinated dogs. This study confirms that SPBN GASGAS is capable of inducing an adequate immune response comparable to a parenteral vaccine under field conditions in Indonesia.
Collapse
Affiliation(s)
- Irene Linda Megawati Saputra
- Directorate of Animal Health, Ministry of Agriculture, Jakarta 12550, Indonesia
- Faculty of Veterinary Medicine, Airlangga University, Surabaya 60115, Indonesia
| | - Suwarno Suwarno
- Faculty of Veterinary Medicine, Airlangga University, Surabaya 60115, Indonesia
| | - Wahid Fakhri Husein
- Emergency Centre for Transboundary Animal Diseases, The Food and Agriculture Organization of the United Nations, Jakarta 12550, Indonesia
| | - Pebi Purwo Suseno
- Directorate of Animal Health, Ministry of Agriculture, Jakarta 12550, Indonesia
| | | | - Ad Vos
- Veterinary Public Health, Ceva SA, 33500 Libourne, France
| | - I Made Arthawan
- Bali Provincial Animal Health Services, Den Pasar 80225, Indonesia
| | - Luuk Schoonman
- Emergency Centre for Transboundary Animal Diseases, The Food and Agriculture Organization of the United Nations, Jakarta 12550, Indonesia
| | - John Weaver
- Australia Indonesia Health Security Partnership, Jakarta 12550, Indonesia
| | - Nuryani Zainuddin
- Directorate of Animal Health, Ministry of Agriculture, Jakarta 12550, Indonesia
| |
Collapse
|
5
|
Rathnadiwakara H, Gunatilake M, Cliquet F, Wasniewski M, Thammitiyagodage M, Karunakaran R, Thibault JC, Ijas M. Detection of immunity in sheep following anti-rabies vaccination. Clin Exp Vaccine Res 2023; 12:97-106. [PMID: 37214148 PMCID: PMC10193110 DOI: 10.7774/cevr.2023.12.2.97] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/12/2023] [Accepted: 01/30/2023] [Indexed: 05/24/2023] Open
Abstract
Purpose Rabies is a fatal but preventable disease with proper pre-exposure anti-rabies vaccination (ARV). Dogs, as household pets and strays, are the reservoir and vector of the disease, and dog bites have been associated with human rabies cases in Sri Lanka over the past few years. However, other susceptible species having frequent contact with humans may be a source of infection. One such species is sheep and immunity following ARV has never been tested in sheep reared in Sri Lanka. Materials and Methods We have tested serum samples from sheep reared in the Animal Centre, Medical Research Institute of Sri Lanka for the presence of anti-rabies antibodies following ARV. Sheep serum samples were tested with Bio-Pro Rabies enzyme-linked immunosorbent assay (ELISA) antibody kits used for the first time in Sri Lanka and our results were verified by a seroneutralization method on cells (fluorescent antibody virus neutralization, FAVN test) currently recommended by World Organization for Animal Health and World Health Organization. Results Sheep received annual ARV and maintained high neutralizing antibody titers in their serum. No maternal antibodies were detected in lamb around 6 months of age. Agreement between the ELISA and FAVN test, i.e., coefficient concordance was 83.87%. Conclusion Annual vaccination in sheep has an effect on maintaining adequate protection against rabies by measurements of anti-rabies antibody response. Lambs need to be vaccinated earlier than 6 months of age to achieve protective levels of neutralizing antibodies in their serum. Introducing this ELISA in Sri Lanka will be a good opportunity to determine the level of anti-rabies antibodies in animal serum samples.
Collapse
Affiliation(s)
| | - Mangala Gunatilake
- Department of Physiology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka
| | - Florence Cliquet
- EU/WOAH/WHO Reference Laboratory for Rabies, OMCL for rabies vaccines, French Agency for Food, Environmental and Occupational Health Safety, Nancy, France
| | - Marine Wasniewski
- EU/WOAH/WHO Reference Laboratory for Rabies, OMCL for rabies vaccines, French Agency for Food, Environmental and Occupational Health Safety, Nancy, France
| | | | | | | | - Mohamed Ijas
- Municipal Veterinary Department, Colombo Municipal Council, Colombo, Sri Lanka
| |
Collapse
|
6
|
Efficacy of Oral Rabies Vaccine Baits Containing SPBN GASGAS in Domestic Dogs According to International Standards. Vaccines (Basel) 2023; 11:vaccines11020307. [PMID: 36851185 PMCID: PMC9967523 DOI: 10.3390/vaccines11020307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2023] [Revised: 01/27/2023] [Accepted: 01/27/2023] [Indexed: 01/31/2023] Open
Abstract
(1) Background: The oral vaccination of free-roaming dogs against rabies has been developed as a promising complementary tool for mass dog vaccination. However, no oral rabies vaccine has provided efficacy data in dogs according to international standards. (2) Methods: To test the immunogenicity and efficacy of the third-generation oral rabies virus vaccine strain, SPBN GASGAS, in domestic dogs, dogs were offered an egg-flavoured bait containing 3.0 mL of the vaccine (107.5 FFU/mL) or a placebo egg-flavoured bait. Subsequently, these 25 vaccinated and 10 control animals were challenged approximately 6 months later with a dog rabies virus isolate. Blood samples were collected at different time points postvaccination and examined by ELISA and RFFIT. (3) Results: All but 1 of the 25 vaccinated dogs survived the challenge infection; meanwhile, all 10 control dogs succumbed to rabies. The serology results showed that all 25 vaccinated dogs seroconverted in ELISA (>40% PB); meanwhile, only 13 of the 25 vaccinated dogs tested seropositive ≥ 0.5 IU/mL) in RFFIT. (4) Conclusions: The SPBN GASGAS rabies virus vaccine meets the efficacy requirements for live oral rabies vaccines as laid down by the European Pharmacopoeia and the WOAH Terrestrial Manual. SPBN GASGAS already fulfilled the safety requirements for oral rabies vaccines targeted at dogs. Hence, the egg-flavoured bait containing SPBN GASGAS is the first oral vaccine bait that complies with WOAH recommendations for the intended use of oral vaccination of free-roaming dogs against rabies.
Collapse
|
7
|
Evaluation of In-House ELISA for Antirabies Antibodies Detection in Domestic Canine. Vet Med Int 2023; 2023:4096258. [PMID: 36743706 PMCID: PMC9891833 DOI: 10.1155/2023/4096258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2022] [Revised: 12/29/2022] [Accepted: 01/05/2023] [Indexed: 01/26/2023] Open
Abstract
Indonesia is known to be endemic for rabies in several areas, especially in Sumatra, Kalimantan, Sulawesi, and Flores Islands. Currently, vaccinating dogs has been shown to be the most cost-effective strategy for preventing rabies in humans. Postvaccination monitoring should be carried out to evaluate the success of vaccination by measuring antibody titers in serum of vaccinated dogs. Serological methods for monitoring rabies-specific antibody titers can be carried out using enzyme-linked immunosorbent assay (ELISA) methods as recommended by the World Organization for Animal Health (WOAH). Therefore, the development of the in-house ELISA (BukTi-Vet) that we have carried out in order to support postvaccination monitoring in dogs needs to be evaluated for its diagnostic performance compared to commercial ELISA kits. The diagnostic performance of each ELISA kit was evaluated using 111 known positive and 47 negative serums. Each known positive and negative serum will be tested using the three rabies ELISA kits used in this study. BukTi-Vet is an in-house ELISA for the detection of rabies-specific IgG antibodies that have been developed with sensitivity, specificity, and accuracy of 98.19%, 97.87%, and 98.1%, respectively. Based on the value of its positive and negative clinical utility index, BukTi-Vet is excellent for use in immunoassays directed for confirmatory (0.97) as well as screening (0.94) tests. BukTi-Vet shows a very good agreement with both Platelia II and RFFIT, so it is convincing to be further refined into a diagnostic kit. Tests of field sera from dogs vaccinated with various vaccines should be performed to provide more complete information on diagnostic performance. BukTi-Vet showed a very good agreement with RFFIT, while Pusvetma and Platelia II only showed good agreement. The average value of BukTi-Vet compatibility with RFFIT can reach 94%.
Collapse
|
8
|
Lobanova VA, Tsarkova KN, Bogomolova OA, Matveeva IN, Klyukina VI. [Competitive ELISA test system for the detection of antibodies to the rabies virus in animals (Rhabdoviridae: <I>Lyssavirus</I>)]. Vopr Virusol 2022; 67:331-340. [PMID: 36097714 DOI: 10.36233/0507-4088-127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Accepted: 09/12/2022] [Indexed: 06/15/2023]
Abstract
INTRODUCTION The main approach to the rabies prevention is the vaccination of domestic and wild carnivores. For the routine evaluation the anti-rabies vaccination effectiveness, World Organization for Animal Health (OIE) recommends various enzyme-linked immunosorbent assays (ELISA).The aim of the study was to design and validate a competitive ELISA (cELISA) test system for the detection of antibodies to the rabies virus (RABV). MATERIALS AND METHODS The development of the cELISA was carried out following the OIE recommendations. RESULTS The repeatability of the cELISA results within one laboratory was satisfactory (coefficient of variation 7.95-13.61%). The coefficient of determination (CD) between the results of the virus neutralization reaction (FAVN) and cELISA was 0.988, p < 0.001. The lower threshold for antibody detection was less than 0.02 IU/ml. The cELISA did not demonstrate cross-reactivity against antibodies to canine distemper virus, parainfluenza virus, parvovirus, coronavirus, and canine adenovirus (types I and II). During the study of 137 dog blood sera, diagnostic specificity (DSp) and diagnostic sensitivity (DSe) for the cELISA were 83.1% and 94.9%, respectively, and CD between the cELISA and FAVN results was 0.968, p < 0.001. DISCUSSION Indirect ELISA test systems for determining the level of antibodies to RABV are not sensitive enough compared to reference tests, unlike cELISA. The developed test system is not inferior for its DSp and DSe to the commercial cELISA BioPro ELISA Rabies Ab (DSp 66.7%, DSe 94.4%). CONCLUSION The developed cELISA test system can be used to detect antibodies to RABV in the blood serum of dogs for evaluating the effectiveness of mass vaccination programs.
Collapse
Affiliation(s)
- V A Lobanova
- All-Russian Research and Technological Institute of Biological Industry; Russian State Agrarian University - Moscow Timiryazev Agricultural Academy
| | - K N Tsarkova
- All-Russian Research and Technological Institute of Biological Industry
| | - O A Bogomolova
- All-Russian Research and Technological Institute of Biological Industry
| | - I N Matveeva
- All-Russian Research and Technological Institute of Biological Industry
| | - V I Klyukina
- All-Russian Research and Technological Institute of Biological Industry
| |
Collapse
|
9
|
RABIES IN ARCTIC FOX (VULPES LAGOPUS) AND REINDEER (RANGIFER TARANDUS PLATYRHYNCHUS) DURING AN OUTBREAK ON SVALBARD, NORWAY, 2011-12. J Wildl Dis 2022; 58:550-561. [PMID: 35666850 DOI: 10.7589/jwd-d-21-00112] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Accepted: 02/21/2022] [Indexed: 11/20/2022]
Abstract
Rabies is an important zoonotic disease with high fatality rates in animals and humans. In the Arctic, the Arctic fox (Vulpes lagopus) is regarded as the principal reservoir, but there is considerable debate about how the disease persists at the low population densities that are typical for this species. We describe an outbreak of rabies among Arctic foxes and Svalbard reindeer (Rangifer tarandus platyrhynchus) during 2011-12 on the remote Arctic archipelago of Svalbard, an area with a very low and relatively stable Arctic fox density. The aim of the research was to increase knowledge of Arctic rabies in this ecosystem and in the presumed spillover host, the Svalbard reindeer. Phylogenetic analysis of rabies virus (RABV) RNA isolates from Arctic fox and reindeer was performed, and clinical observations and histologic and immunohistochemical findings in reindeer were described. An ongoing capture-mark-recapture project allowed collection of serum samples from clinically healthy reindeer from the affected population for detection of rabies virus-neutralizing antibodies. The outbreak was caused by at least two different variants belonging to the RABV Arctic-2 and Arctic-3 clades, which suggests that rabies was introduced to Svalbard on at least two different occasions. The RABV variants found in Arctic fox and reindeer were similar within locations, suggesting that Arctic foxes and reindeer acquired the infection from the same source(s). The histopathologic and immunohistochemical findings in 10 reindeer were consistent with descriptions in other species infected with RABV of non-Arctic lineages. Evidence of RABV was detected in both brain and salivary gland samples. None of 158 examined serum samples from clinically healthy reindeer had virus-neutralizing antibodies against RABV.
Collapse
|
10
|
Filter Papers to Collect Blood Samples from Dogs: An Easier Way to Monitor the Mass Vaccination Campaigns against Rabies? Viruses 2022; 14:v14040711. [PMID: 35458439 PMCID: PMC9029112 DOI: 10.3390/v14040711] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/28/2022] [Revised: 03/21/2022] [Accepted: 03/23/2022] [Indexed: 12/25/2022] Open
Abstract
Rabies is a deadly viral disease present mainly in low-income countries of Africa and Asia. Dogs are the main reservoir and the source of human deaths. Mass vaccination campaigns of dogs are pivotal to achieve rabies elimination. The monitoring of the immune response of the dog population is necessary to evaluate the effectiveness of these campaigns, taking into account field conditions. This study explores the feasibility and the performance of a new tool using filter papers (FPs) to collect blood samples associated with an Enzyme-Linked ImmunoSorbent Assay (ELISA) titration of rabies antibodies in dogs. A total of 216 eluates from FP samples were collected from 111 dogs kept in experimental facilities in France and 29 dogs from the field in Tunisia. Sera were also analyzed using both the Fluorescence Antibody Virus Neutralization test (FAVNt) and ELISA. A high specificity (98.0%) was obtained by testing FP blood eluates from 51 unvaccinated dogs, with the results compared with those of FAVNt and ELISA on serum samples. The coefficients of concordance between FP eluates and tested sera were 88.9% for FAVNt and 88.0% for ELISA. Blood filter papers coupled with the titration of rabies antibodies by ELISA provide a reliable, simple, and effective solution to overcome the issues of the logistics and transport of samples, especially in low-income countries.
Collapse
|
11
|
Ciconello FN, Katz ISS, Fernandes ER, Guedes F, Silva SR. A comparative review of serological assays for the detection of rabies virus-specific antibodies. Acta Trop 2022; 226:106254. [PMID: 34808119 DOI: 10.1016/j.actatropica.2021.106254] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2021] [Revised: 11/15/2021] [Accepted: 11/17/2021] [Indexed: 12/25/2022]
Abstract
Rabies is a major public health problem with a fatality rate close to 100%, caused by a virus of the Lyssavirus genus, of which rabies virus (RABV) is the prototype. Nonetheless, the complete prevention can be achieved by the induction of neutralizing antibodies by pre- or post-exposure prophylaxis. According to the world health organization (WHO) and World Organization for animal health (OIE), serum titers of rabies virus neutralizing antibodies (RVNA) that are higher or equal to 0.5 international units (IU)/ml indicate adequate immune response after vaccination against rabies. Currently, RFFIT and FAVN are the gold standard tests recommended by both WHO and OIE for detecting and quantitating RVNA in biological samples from individuals or animals previously vaccinated and/or subjects suspected of having been infected by RABV. Although the tests RFFIT and FAVN are efficient, they are time-consuming, labor-intensive manual tests and not cost-effective for routine use. Following the previously mentioned, approaches with alternative methods have been developed to detect RVNA or rabies-specific antibodies in human or animal serum, but with variable success. This work summarizes the advances in the serological assays for the detection of neutralizing antibodies or rabies antibodies and assesses the individual immune status after vaccination against rabies, as well as the mechanisms of RABV neutralization mediated by antibodies. Therefore, the main alternative methods for the determination of RABV or rabies-specific antibodies are exposed, with promising results, besides being easy to execute, of low cost, and representing a possibility of being applied, according to the proposal of each test to the network of Rabies Surveillance Laboratories.
Collapse
|
12
|
Rabies Vaccination in Dogs in Laos: Owner Knowledge and Serological Status of Dogs. Pathogens 2022; 11:pathogens11010069. [PMID: 35056017 PMCID: PMC8778959 DOI: 10.3390/pathogens11010069] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2021] [Revised: 12/29/2021] [Accepted: 12/30/2021] [Indexed: 02/06/2023] Open
Abstract
Rabies is an infectious disease which is virtually 100% fatal. Humans are most often infected through the bite of an infected dog, and most cases could be prevented by vaccinating dogs. However, vaccination coverage is insufficient in most countries where canine rabies occurs endemically. This study conducted interviews and sampling of dogs in Laos to understand more about the barriers for vaccination and to evaluate the antibody status of dogs using a commercial ELISA. The study found that only 62% out of 359 dog owners knew what rabies was, and only 24% knew the disease could be fatal. Higher education was associated with higher knowledge scores. Only 56 out of 437 (13%) dogs had been rabies vaccinated according to their owner, and out of these dogs, only 34 (61%) had antibodies, and only 48% had adequate levels (above 0.5 IU/mL). However, 24% of the dogs with no known history of vaccination had antibodies, indicating either exposure or vaccination in the past without the owner's awareness. In conclusion, this study indicates that there is a low level of knowledge about rabies, and that owner knowledge is not a good indicator of whether a dog is vaccinated or not.
Collapse
|
13
|
Molini U, Hassel R, Ortmann S, Vos A, Loschke M, Shilongo A, Freuling CM, Müller T. Immunogenicity of the Oral Rabies Vaccine Strain SPBN GASGAS in Dogs Under Field Settings in Namibia. Front Vet Sci 2021; 8:737250. [PMID: 34760958 PMCID: PMC8573107 DOI: 10.3389/fvets.2021.737250] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2021] [Accepted: 09/22/2021] [Indexed: 12/22/2022] Open
Abstract
Dog-mediated rabies is endemic throughout Africa. While free-roaming dogs that play a crucial role in rabies transmission are often inaccessible for parenteral vaccination during mass dog vaccination campaigns, oral rabies vaccination (ORV) is considered to be a promising alternative to increase vaccination coverage in these hard-to-reach dogs. The acceptance of ORV as an efficient supplementary tool is still low, not least because of limited immunogenicity and field trial data in local dogs. In this study, the immunogenicity of the highly attenuated 3rd-generation oral rabies vaccine strain SPBN GASGAS in local free-roaming dogs from Namibia was assessed by determining the immune response in terms of seroconversion for up to 56 days post-vaccination. At two study sites, free-roaming dogs were vaccinated by administering the vaccine either by direct oral administration or via a vaccine-loaded egg bait. Pre- and post-vaccination blood samples were tested for rabies virus neutralizing as well as binding antibodies using standard serological assays. A multiple logistic regression (MLR) analysis was performed to determine a possible influence of study area, vaccination method, and vaccine dose on the seroconversion rate obtained. About 78% of the dogs vaccinated by the oral route seroconverted (enzyme-linked immunosorbent assay, ELISA), though the seroconversion as determined by a rapid fluorescence focus inhibition test (RFFIT) was much lower. None of the factors examined had a significant effect on the seroconversion rate. This study confirms the immunogenicity of the vaccine strain SPBN GASGAS and the potential utility of ORV for the control of dog-mediated rabies in African dogs.
Collapse
Affiliation(s)
- Umberto Molini
- School of Veterinary Medicine, University of Namibia, Windhoek, Namibia
| | - Rainer Hassel
- School of Veterinary Medicine, University of Namibia, Windhoek, Namibia
| | - Steffen Ortmann
- Ceva Innovation Center, Ceva Santé Animale, Dessau-Roßlau, Germany
| | - Ad Vos
- Ceva Innovation Center, Ceva Santé Animale, Dessau-Roßlau, Germany
| | - Malaika Loschke
- School of Veterinary Medicine, University of Namibia, Windhoek, Namibia
| | - Albertina Shilongo
- Directorate of Veterinary Services, Ministry of Agriculture, Water and Land Reform, Windhoek, Namibia
| | - Conrad M Freuling
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Riems, Germany
| | - Thomas Müller
- Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, Riems, Germany
| |
Collapse
|
14
|
Su K, Xue J, Shan X, Ye H, Zhang L, Tan S, Shao J, Shi Y, Wang Z, Zhang L. Review of Detection and Quantification of Rabies Virus Antibodies. Viral Immunol 2021; 34:522-530. [PMID: 34550784 DOI: 10.1089/vim.2020.0317] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
Rabies is an almost invariably fatal disease. According to the World Health Organization (WHO), rabies virus neutralizing antibody (RVNA) titers of ≥0.5 IU/mL are considered adequate for rabies protection. Therefore, detection and quantification of RABV antibodies are important. Many methods have been developed for detecting RABV antibodies. In the present study, we reviewed several methods of detecting RABV antibodies in human and animal samples and evaluated and compared their performance. Of 34 methods, 5 demonstrated unsatisfactory sensitivity or specificity. The others exhibited sensitivity and specificity of ≥75%. The correlation coefficient for five of eight methods was >0.8. The Bland-Altman mean bias of five of five methods was <±2.0. The kappa values of 25 of 28 methods were higher than 0.4, demonstrating at least moderate agreement. Analysis of the performance of these methods emphasized that any new technology should be considered carefully and objectively before being used as an appropriate and applicable alternative.
Collapse
Affiliation(s)
- Kewen Su
- Department of Sanitary Analysis, Hangzhou Hospital for the Prevention and Treatment of Occupational Disease, Hangzhou, China
| | - Jian Xue
- School of Public Health and Management, Chongqing Medical University, Chongqing, China
| | - Xiaoyue Shan
- Department of Sanitary Analysis, Hangzhou Hospital for the Prevention and Treatment of Occupational Disease, Hangzhou, China
| | - Haipeng Ye
- Department of Sanitary Analysis, Hangzhou Hospital for the Prevention and Treatment of Occupational Disease, Hangzhou, China
| | - Ling Zhang
- Department of Sanitary Analysis, Hangzhou Hospital for the Prevention and Treatment of Occupational Disease, Hangzhou, China
| | - Siwei Tan
- Department of Sanitary Analysis, Hangzhou Hospital for the Prevention and Treatment of Occupational Disease, Hangzhou, China
| | - Ji Shao
- Department of Sanitary Analysis, Hangzhou Hospital for the Prevention and Treatment of Occupational Disease, Hangzhou, China
| | - Yanpeng Shi
- Department of Sanitary Analysis, Hangzhou Hospital for the Prevention and Treatment of Occupational Disease, Hangzhou, China
| | - Zhe Wang
- Institute for Communicable Disease Control and Prevention, Hangzhou Center for Disease Control and Prevention, Hangzhou, China
| | - Lei Zhang
- Department of Sanitary Analysis, Hangzhou Hospital for the Prevention and Treatment of Occupational Disease, Hangzhou, China
| |
Collapse
|
15
|
Rodriguez MC, Fontana D, Garay E, Prieto C. Detection and quantification of anti-rabies glycoprotein antibodies: current state and perspectives. Appl Microbiol Biotechnol 2021; 105:6547-6557. [PMID: 34448897 PMCID: PMC8390338 DOI: 10.1007/s00253-021-11515-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2021] [Revised: 08/06/2021] [Accepted: 08/10/2021] [Indexed: 12/25/2022]
Abstract
Rabies is an ancient fatal disease with no other available treatment than post-exposure vaccination, where the bite of infected animals, mainly dogs, is the leading cause of its transmission to human beings. In this context, global vaccination campaigns of companion animals, as well as wildlife reservoirs vaccination, are key factors to achieve the "Zero by 30" plan that pursues the eradication of dog-mediated human rabies by 2030. Rabies virus-neutralizing antibodies (VNAs) play an essential role in the disease protection, as it correlates with an adequate immune response and allows evaluating pre- or post-exposure prophylaxis efficacy. Hence, counting with reliable, accurate, and robust serological tests is of paramount importance. Currently, RFFIT and FAVN are the gold standard VNAs tests recommended by both the WHO and the OIE. Despite these methodologies are efficient and widely used, they present several drawbacks, as they are less easily to standardize and require the use of live rabies virus, containment facilities, and skilled professionals. Thus, in this review, we describe the state-of-the-art of alternative analytical methodologies currently available for rabies serology, with novel approaches based on pseudotyped recombinant viruses and emphasizing in the antigen binding methodologies that detect and quantify antibodies against the rabies glycoprotein. We discussed the wide range of assays that are interesting tools for a faster measurement of anti-rabies glycoprotein antibodies and, in some cases, less complex and more versatile than the gold standard methods. Finally, we discussed the key issues during the design and optimization steps of ELISA assays, highlighting the importance of validation and standardization procedures to improve rabies serology tests and, as a consequence, their results. KEY POINTS: • An exhaustive revision of rabies serology testing was made. • No rabies serology assay can be thought as better than others for all intents and purposes. • The validation procedure guarantees reliable and consistent results among the globe.
Collapse
Affiliation(s)
- Maria Celeste Rodriguez
- UNL, CONICET, FBCB (School of Biochemistry and Biological Sciences), CBL (Biotechnological Center of Litoral), Cell Culture Laboratory, Ciudad Universitaria, Ruta Nacional 168 - Km 472.4 - C.C. 242 - (S3000ZAA), Santa Fe, Argentina
| | - Diego Fontana
- UNL, CONICET, FBCB (School of Biochemistry and Biological Sciences), CBL (Biotechnological Center of Litoral), Cell Culture Laboratory, Ciudad Universitaria, Ruta Nacional 168 - Km 472.4 - C.C. 242 - (S3000ZAA), Santa Fe, Argentina.
| | - Ernesto Garay
- UNL, CONICET, FBCB (School of Biochemistry and Biological Sciences), CBL (Biotechnological Center of Litoral), Cell Culture Laboratory, Ciudad Universitaria, Ruta Nacional 168 - Km 472.4 - C.C. 242 - (S3000ZAA), Santa Fe, Argentina
| | - Claudio Prieto
- UNL, FBCB (School of Biochemistry and Biological Sciences), CBL (Biotechnological Center of Litoral), Biotechnological Development Laboratory, Ciudad Universitaria, Ruta Nacional 168 - Km 472.4 - C.C. 242 - (S3000ZAA), Santa Fe, Argentina
| |
Collapse
|
16
|
Zandi M, Zandi S, Mohammadi R, Hosseini P, Teymouri S, Soltani S, Rasouli A. Biosensor as an alternative diagnostic method for rabies virus detection: A literature review. Biotechnol Appl Biochem 2021; 69:1348-1353. [PMID: 34056785 DOI: 10.1002/bab.2207] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2021] [Accepted: 05/27/2021] [Indexed: 01/11/2023]
Abstract
Rabies virus as a neurotropic agent causes rabies in humans and animals. Rabies virus transmission usually occurs through direct contact with saliva of rabid animals. However, serological and molecular tests commonly are used in diagnosing rabies but all the detection methods of rabies have some limitations. It is necessary to develop a rapid, effective, and low-cost biosensor as an alternative tool to detect rabies virus. In this review, we studied related biosensor researches to rabies virus detection for comparing it with other detection test including serological and molecular methods. Given that very limited studies have been conducted in this field, biosensors as quick, effective, and high sensitivity tools can be used in diagnostic of rabies as an alternative tool instead of other detection methods. According to the important role of rapid detection of rabies in the control of infection and public health measures, development of a biosensor as a quick tool can be very significant in the diagnosis of rabies.
Collapse
Affiliation(s)
- Milad Zandi
- Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.,Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
| | - Sajad Zandi
- Department of Electrical Engineering, Malayer University, Malayer, Iran
| | - Ramin Mohammadi
- Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, Canada
| | - Parastoo Hosseini
- Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.,Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
| | - Samane Teymouri
- Microbial Biotechnology Research Center, Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
| | - Saber Soltani
- Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.,Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran
| | - Azadeh Rasouli
- Department of Virology, Pasteur Institute of Iran, Tehran, Iran.,Department of Biochemistry, Faculty of Sciences, Payame Noor University, Tehran, Iran
| |
Collapse
|
17
|
Zienius D, Mickutė J, Pautienius A, Grigas J, Stankevičius A, Pridotkas G, Jacevičius E, Kemeraitė J, Jacevičienė I. Analysis of seroprevalence in target wildlife during the oral rabies vaccination programme in Lithuania. Acta Vet Scand 2021; 63:12. [PMID: 33743780 PMCID: PMC7981835 DOI: 10.1186/s13028-021-00577-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2020] [Accepted: 03/08/2021] [Indexed: 11/21/2022] Open
Abstract
BACKGROUND Rabies vaccination of wildlife carnivores is a powerful tool to prevent, control and eliminate rabies. The presence of neutralizing rabies antibodies in blood is considered a reliable indicator of adequate vaccination. The main purpose of the present study was to analyze the seroprevalence of specific antibodies in target populations of Lithuanian red fox (RF) and raccoon dog (RD) during the oral rabies vaccination (ORV) campaigns during the 2010-2019 period. RESULTS Over the ten-year period, 7,261 RF and 2,146 RD sera samples were collected post-mortem in field conditions and tested using a commercial standardized enzyme-linked immunosorbent assay (ELISA) kit in Lithuania. In the ORV spring and autumn vaccination periods, 31.8% (20.3-43.4 95% CI - 95% confidence interval) and 31.7% (21.2-42.1 95% CI) of RF, and 34.1% (22.5-45.7 95% CI) and 34.7% (22.7-46.7 95% CI) of RD sera samples, respectively, were identified as ELISA-positive (seroconversion ≥ 0.5 EU/mL-Equivalent Units per Millilitre). The seroprevalence analysis in adult/ juvenile animal subpopulations indicated that 34.9% (27.2-42.5 95% CI) and 29.2% (20.3-37.9 95% CI) of RF, and 35.6% (25.2-46.0 95% CI) and 30.6% (20.2-40.9 95% CI) of RD sera samples, respectively, were identified as ELISA-positive (seroconversion ≥ 0.5 EU/mL). Statistically strong determinate correlations (r) between the serological results (pos.%) in RF adult/juvenile animal subpopulations (r = 0.937) and between RF and RD positive seroconvert (pos.%) sera samples during the spring vaccinations (r = 0.864) were demonstrated. In different ORV periods, 14-29% of RF and 7-25% of RD sera samples were identified as ELISA-negative (seroconversion < 0.5 EU/mL), but with low (0.125 < 0.49 EU/mL) antibody (Abs) titres. CONCLUSIONS The 2010-2019 ORV programme has been an effective tool in both RF and RD populations in Lithuania. The rabies-free status of Lithuania was self-declared in 2015 with only three rabies cases identified in buffer zones since then. The percentage of ELISA-positive serum samples (seroconversion ≥ 0.5 EU/mL) during the different periods of vaccination was similar in RF and RD populations-32% and 34% respectively. The identified seroconversion average of 21.5% in RF and 16% in RD sera samples were officially identified as ELISA-negative (seronversion < 0.5 EU/mL), but with low 0.125 < 0.49 EU/mL Abs titres. That low, but positive seroconversion participated in the formation of populations overall immune status and can influence the interpretation of oral vaccination efficacy.
Collapse
Affiliation(s)
- Dainius Zienius
- Lithuanian University of Health Sciences, Institute of Microbiology and Virology, Lithuania, Tilžės str. 18, 47181 Kaunas, Lithuania
| | - Janina Mickutė
- Lithuanian University of Health Sciences, Institute of Microbiology and Virology, Lithuania, Tilžės str. 18, 47181 Kaunas, Lithuania
| | - Arnoldas Pautienius
- Lithuanian University of Health Sciences, Institute of Microbiology and Virology, Lithuania, Tilžės str. 18, 47181 Kaunas, Lithuania
| | - Juozas Grigas
- Lithuanian University of Health Sciences, Institute of Microbiology and Virology, Lithuania, Tilžės str. 18, 47181 Kaunas, Lithuania
| | - Arunas Stankevičius
- Lithuanian University of Health Sciences, Institute of Microbiology and Virology, Lithuania, Tilžės str. 18, 47181 Kaunas, Lithuania
| | - Gediminas Pridotkas
- National Food and Veterinary Risk Assessment Institute, National Food and Veterinary Risk Assessment Institute, J. Kairiūkščio str. 10, 08409 Vilnius, Lithuania
| | - Eugenijus Jacevičius
- National Food and Veterinary Risk Assessment Institute, National Food and Veterinary Risk Assessment Institute, J. Kairiūkščio str. 10, 08409 Vilnius, Lithuania
| | - Jolita Kemeraitė
- National Food and Veterinary Risk Assessment Institute, National Food and Veterinary Risk Assessment Institute, J. Kairiūkščio str. 10, 08409 Vilnius, Lithuania
| | - Ingrida Jacevičienė
- National Food and Veterinary Risk Assessment Institute, National Food and Veterinary Risk Assessment Institute, J. Kairiūkščio str. 10, 08409 Vilnius, Lithuania
| |
Collapse
|
18
|
Rossouw L, Boshoff C, Sabeta C, Kotzé J. A preliminary investigation of exposure to rabies virus in selected wildlife in the Kruger National Park, South Africa. KOEDOE: AFRICAN PROTECTED AREA CONSERVATION AND SCIENCE 2021. [DOI: 10.4102/koedoe.v63i1.1651] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/01/2022]
|
19
|
Meza DK, Broos A, Becker DJ, Behdenna A, Willett BJ, Viana M, Streicker DG. Predicting the presence and titre of rabies virus-neutralizing antibodies from low-volume serum samples in low-containment facilities. Transbound Emerg Dis 2020; 68:1564-1576. [PMID: 32931658 DOI: 10.1111/tbed.13826] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2020] [Revised: 08/03/2020] [Accepted: 09/03/2020] [Indexed: 12/11/2022]
Abstract
Serology is a core component of the surveillance and management of viral zoonoses. Virus neutralization tests are a gold standard serological diagnostic, but requirements for large volumes of serum and high biosafety containment can limit widespread use. Here, focusing on Rabies lyssavirus, a globally important zoonosis, we developed a pseudotype micro-neutralization rapid fluorescent focus inhibition test (pmRFFIT) that overcomes these limitations. Specifically, we adapted an existing micro-neutralization test to use a green fluorescent protein-tagged murine leukaemia virus pseudotype in lieu of pathogenic rabies virus, reducing the need for specialized reagents for antigen detection and enabling use in low-containment laboratories. We further used statistical models to generate rapid, quantitative predictions of the probability and titre of rabies virus-neutralizing antibodies from microscopic imaging of neutralization outcomes. Using 47 serum samples from domestic dogs with neutralizing antibody titres estimated using the fluorescent antibody virus neutralization test (FAVN), pmRFFIT showed moderate sensitivity (78.79%) and high specificity (84.62%). Despite small conflicts, titre predictions were correlated across tests repeated on different dates both for dog samples (r = 0.93) and in a second data set of sera from wild common vampire bats (r = 0.72, N = 41), indicating repeatability. Our test uses a starting volume of 3.5 µl of serum, estimates titres from a single dilution of serum rather than requiring multiple dilutions and end point titration, and may be adapted to target neutralizing antibodies against alternative lyssavirus species. The pmRFFIT enables high-throughput detection of rabies virus-neutralizing antibodies in low-biocontainment settings and is suited to studies in wild or captive animals where large serum volumes cannot be obtained.
Collapse
Affiliation(s)
- Diana K Meza
- Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.,Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow, UK
| | - Alice Broos
- Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.,Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow, UK
| | - Daniel J Becker
- Department of Biology, Indiana University, Bloomington, IN, USA
| | - Abdelkader Behdenna
- Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
| | - Brian J Willett
- Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow, UK
| | - Mafalda Viana
- Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK
| | - Daniel G Streicker
- Institute of Biodiversity, Animal Health and Comparative Medicine, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.,Medical Research Council, University of Glasgow Centre for Virus Research, Glasgow, UK
| |
Collapse
|
20
|
Bian L, Zhao H, He C, Fang H, Chen Z, Lin L, Ye K, Wu Y, Lin G. A time-resolved fluoroimmunoassay for assessing rabies antibody titers in the sera of vaccinated human subjects. Biologicals 2020; 68:54-59. [PMID: 32868168 DOI: 10.1016/j.biologicals.2020.08.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Revised: 08/15/2020] [Accepted: 08/17/2020] [Indexed: 12/20/2022] Open
Abstract
Several studies have investigated the use of simple in vitro tests for the assessment of rabies antibody titers in serum samples from vaccinated human subjects, which would allow the effectiveness of rabies vaccination to be conveniently evaluated. To this end, a novel time-resolved fluoroimmunoassay (TRFIA) for the assessment of rabies antibody titers was established in this study for evaluating the effectiveness of protection against rabies. The TRFIA had a satisfactory limit of detection value (0.035 IU/mL) under optimal conditions. Additionally, the application of the TRFIA was demonstrated in 68 serum samples with satisfactory results. The coefficient variations (CVs) were all <10%, and the recoveries were in the range of 90-110%. The correlation coefficient of titer values obtained using the present TRFIA and the rapid fluorescent focus inhibition test (RFFIT) was 0.733, with a coincidence rate regarding the evaluation results (protected or not protected by vaccination) of 100%. The preliminary results confirmed that the TRFIA had a higher performance than an enzyme-linked immunosorbent assay (ELISA), and could potentially replace the ELISA. Based on these results, the novel TRFIA appears to be a convenient tool for the evaluation of rabies vaccination results based on serum samples from vaccinated human subjects.
Collapse
Affiliation(s)
- Lun Bian
- Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China
| | - Hui Zhao
- Department of Plastic and Aesthetic Surgery, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China
| | - Chunhui He
- Guangzhou Promise Biologics Co., Ltd, No. 1 Wanbao North Street, Panyu District, Guangzhou, Guangdong, China
| | - Haolin Fang
- Guangzhou Promise Biologics Co., Ltd, No. 1 Wanbao North Street, Panyu District, Guangzhou, Guangdong, China
| | - Zhenhua Chen
- Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China
| | - Li Lin
- Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China
| | - Ke Ye
- Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China
| | - Yingsong Wu
- Institute of Antibody Engineering, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
| | - Guanfeng Lin
- Experimental Center of Teaching and Scientific Research, School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, China.
| |
Collapse
|
21
|
Orłowska A, Smreczak M, Freuling CM, Müller T, Trębas P, Rola J. Serological Survey of Lyssaviruses in Polish Bats in the Frame of Passive Rabies Surveillance Using an Enzyme-Linked Immunosorbent Assay. Viruses 2020; 12:v12030271. [PMID: 32121200 PMCID: PMC7150987 DOI: 10.3390/v12030271] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2019] [Revised: 02/17/2020] [Accepted: 02/27/2020] [Indexed: 12/27/2022] Open
Abstract
Background: Bats are known to host a number of nonpathogenic viruses, as well as highly pathogenic viruses causing fatal diseases like rabies. Serological surveys as part of active and passive bat rabies surveillance mainly use seroneutralization assays, demonstrating the presence of lyssavirus-specific antibodies in a variety of European bats, particularly against European bat lyssaviruses type 1 (EBLV-1). Here, we present the first serological survey in European bats of this kind during which European bats from Poland collected in the frame of passive rabies surveillance between 2012 and 2018, as well as Serotine bats (Eptesicus serotinus) and North American Big Brown bats (Eptesicus fuscus) from previous experimental studies, were tested using a commercial ELISA kit for the detection of anti-lyssavirus antibodies. Results: Lyssavirus-specific antibodies were detected in 35 (30.4%) out of 115 Polish bats of both sexes, representing nine out of 13 identified bat species endemic mainly to Central Southern Europe and Western Asia, i.e., Eptesicus serotinus, Nyctalus noctula, Myotis daubentonii, Plecotus auritus, Vespertillo murinus, Pipistrellus pipistrellus, Pipistrellus pipilstrellus/Pipistrellus pygmaeus, Myotis brandtii, and Barbastella barbastellus. Seroprevalence was highest in bat species of Nyctalus noctula, Eptesicus serotinus, Plecotus auritus, and Myotis daubentonii. More than 60% of the ELISA seropositive bats originated from the voivodeships of Silesia, Lower-Silesian, Warmian-Mazurian, and Mazowian. Rabies-specific antibodies were also found in Eptesicus fuscus bats from North America. Conclusions: The study demonstrates the principal application of the BioPro Rabies ELISA Ab Kit for the detection of anti-lyssavirus specific antibodies in body fluids and serum samples of bats. However, results may only be reliable for North American bats, whereas interpretation of results for European bats per se is difficult because proper validation of the test is hampered by the protected status of these species.
Collapse
Affiliation(s)
- Anna Orłowska
- Department of Virology, National Veterinary Research Institute, 24-100 Puławy, Poland; (P.T.); (J.R.)
- Correspondence: (A.O.); (M.S.); Tel.: +48-818-893-072 (A.O.); +48818-893-029 (M.S.)
| | - Marcin Smreczak
- Department of Virology, National Veterinary Research Institute, 24-100 Puławy, Poland; (P.T.); (J.R.)
- Correspondence: (A.O.); (M.S.); Tel.: +48-818-893-072 (A.O.); +48818-893-029 (M.S.)
| | - Conrad Martin Freuling
- Institute of Molecular Virology and Cell Biology, FLI, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany; (C.M.F.); (T.M.)
| | - Thomas Müller
- Institute of Molecular Virology and Cell Biology, FLI, WHO Collaborating Centre for Rabies Surveillance and Research, OIE Reference Laboratory for Rabies, 17493 Greifswald-Insel Riems, Germany; (C.M.F.); (T.M.)
| | - Paweł Trębas
- Department of Virology, National Veterinary Research Institute, 24-100 Puławy, Poland; (P.T.); (J.R.)
| | - Jerzy Rola
- Department of Virology, National Veterinary Research Institute, 24-100 Puławy, Poland; (P.T.); (J.R.)
| |
Collapse
|
22
|
Gold S, Donnelly CA, Nouvellet P, Woodroffe R. Rabies virus-neutralising antibodies in healthy, unvaccinated individuals: What do they mean for rabies epidemiology? PLoS Negl Trop Dis 2020; 14:e0007933. [PMID: 32053628 PMCID: PMC7017994 DOI: 10.1371/journal.pntd.0007933] [Citation(s) in RCA: 30] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Rabies has been a widely feared disease for thousands of years, with records of rabid dogs as early as ancient Egyptian and Mesopotamian texts. The reputation of rabies as being inevitably fatal, together with its ability to affect all mammalian species, contributes to the fear surrounding this disease. However, the widely held view that exposure to the rabies virus is always fatal has been repeatedly challenged. Although survival following clinical infection in humans has only been recorded on a handful of occasions, a number of studies have reported detection of rabies-specific antibodies in the sera of humans, domestic animals, and wildlife that are apparently healthy and unvaccinated. These 'seropositive' individuals provide possible evidence of exposure to the rabies virus that has not led to fatal disease. However, the variability in methods of detecting these antibodies and the difficulties of interpreting serology tests have contributed to an unclear picture of their importance. In this review, we consider the evidence for rabies-specific antibodies in healthy, unvaccinated individuals as indicators of nonlethal rabies exposure and the potential implications of this for rabies epidemiology. Our findings indicate that whilst there is substantial evidence that nonlethal rabies exposure does occur, serology studies that do not use appropriate controls and cutoffs are unlikely to provide an accurate estimate of the true prevalence of nonlethal rabies exposure.
Collapse
Affiliation(s)
- Susannah Gold
- Institute of Zoology, Zoological Society of London, London, United Kingdom
- MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom
| | - Christl A. Donnelly
- MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom
- Department of Statistics, University of Oxford, Oxford, United Kingdom
| | - Pierre Nouvellet
- School of Life Sciences, University of Sussex, Falmer, United Kingdom
| | - Rosie Woodroffe
- Institute of Zoology, Zoological Society of London, London, United Kingdom
| |
Collapse
|
23
|
Dascalu MA, Wasniewski M, Picard-Meyer E, Servat A, Daraban Bocaneti F, Tanase OI, Velescu E, Cliquet F. Detection of rabies antibodies in wild boars in north-east Romania by a rabies ELISA test. BMC Vet Res 2019; 15:466. [PMID: 31864363 PMCID: PMC6925894 DOI: 10.1186/s12917-019-2209-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2019] [Accepted: 12/09/2019] [Indexed: 11/30/2022] Open
Abstract
Background In the last few decades, Romania has been considered one of the European countries most affected by animal rabies, but a combination of oral rabies vaccination (ORV) campaigns in foxes alongside mandatory vaccination of pets has substantially decreased the number of rabies cases in recent years. The objective of this study was to detect rabies antibodies in wild boar serum and thoracic fluid samples collected during the hunting season after ORV campaigns in north-eastern Romania in order to identify if wild boars are substantial competitors to foxes for ORV baits. Results When the 312 wild boar samples were tested by ELISA (BioPro ELISA, Czech Republic), 42.31% (132/312) demonstrated rabies antibodies. In order to compare these wild boar results in terms of the percentage of immunisation, fox samples were also included in the study, and in this case only 28.40% (98/345) demonstrated rabies antibodies by ELISA. To check the diagnostic sensitivity and specificity of this ELISA, those samples with a sufficient volume from both species that had tested either negative or positive with an initial ELISA were then tested with the Fluorescent Antibody Virus Neutralisation (FAVN) assay. The overall concordance between the BioPro ELISA and FAVN test was 74.26% (75/101) in wild boar samples and 65.66% (65/99) in fox samples, 140 out of 200 samples being correlated with the two methods, although no significant statistical difference (p = 0.218) between the two species was registered. We found a good agreement by both tests for the ELISA-positive samples (91.30%), however the situation was different for the ELISA-negative samples, where a low agreement was demonstrated (41.18%). Conclusions This study reports for the first time the presence of rabies antibodies in wild boar samples collected during the hunting season in Romania after ORV campaigns in rabies endemic areas. It is also the first study to demonstrate that ELISA BioPro can be used on wild boar samples with satisfactory results compared to the FAVN test for this species.
Collapse
Affiliation(s)
- Mihaela Anca Dascalu
- Department of Public Health, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" University of Agricultural Sciences and Veterinary Medicine, Mihail Sadoveanu Alley, No. 8, 700489, Iasi, Romania.
| | - Marine Wasniewski
- ANSES, Nancy Laboratory for Rabies and Wildlife, WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, Technopôle Agricole et Vétérinaire, CS 40009, 54220, Malzéville, France
| | - Evelyne Picard-Meyer
- ANSES, Nancy Laboratory for Rabies and Wildlife, WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, Technopôle Agricole et Vétérinaire, CS 40009, 54220, Malzéville, France
| | - Alexandre Servat
- ANSES, Nancy Laboratory for Rabies and Wildlife, WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, Technopôle Agricole et Vétérinaire, CS 40009, 54220, Malzéville, France
| | - Florentina Daraban Bocaneti
- Department of Public Health, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" University of Agricultural Sciences and Veterinary Medicine, Mihail Sadoveanu Alley, No. 8, 700489, Iasi, Romania
| | - Oana Irina Tanase
- Department of Public Health, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" University of Agricultural Sciences and Veterinary Medicine, Mihail Sadoveanu Alley, No. 8, 700489, Iasi, Romania
| | - Elena Velescu
- Department of Public Health, Faculty of Veterinary Medicine, "Ion Ionescu de la Brad" University of Agricultural Sciences and Veterinary Medicine, Mihail Sadoveanu Alley, No. 8, 700489, Iasi, Romania
| | - Florence Cliquet
- ANSES, Nancy Laboratory for Rabies and Wildlife, WHO Collaborating Centre for Research and Management in Zoonoses Control, OIE Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, Technopôle Agricole et Vétérinaire, CS 40009, 54220, Malzéville, France
| |
Collapse
|
24
|
Highly efficient production of rabies virus glycoprotein G ectodomain in Sf9 insect cells. 3 Biotech 2019; 9:385. [PMID: 31656723 DOI: 10.1007/s13205-019-1920-4] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2019] [Accepted: 09/24/2019] [Indexed: 10/25/2022] Open
Abstract
In the present study, we developed a complete process to produce in insect cells a high amount of the ectodomain of rabies virus glycoprotein G (GE) as suitable antigen for detecting anti-rabies antibodies. Using the baculovirus expression vector system in Sf9 insect cells combined with a novel chimeric promoter (polh-pSeL), the expression level reached a yield of 4.1 ± 0.3 mg/L culture, which was significantly higher than that achieved with the standard polh promoter alone. The protein was recovered from the cell lysates and easily purified in only one step by metal ion affinity chromatography, with a yield of 95% and a purity of 87%. Finally, GE was successfully used in an assay to detect specific antibodies in serum samples derived from rabies-vaccinated animals. The efficient strategy developed in this work is an interesting method to produce high amounts of this glycoprotein.
Collapse
|
25
|
Debnath A, Pathak DC, Ramamurthy N, Mohd G, Pandey AB, Upmanyu V, Tiwari AK, Saravanan R, Chellappa MM, Dey S. Serological profiling of rabies antibodies by enzyme-linked immunosorbent assay and its comparative analysis with rapid fluorescent focus inhibition test in mouse model. Vet World 2019; 12:126-130. [PMID: 30936665 PMCID: PMC6431817 DOI: 10.14202/vetworld.2019.126-130] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2018] [Accepted: 12/11/2018] [Indexed: 11/30/2022] Open
Abstract
Aim: In this study, we have used enzyme-linked immunosorbent assay (ELISA) as an alternative test to replace the cumbersome rapid fluorescent focus inhibition test (RFFIT) to ascertain the immune status of immunized mice against rabies virus. Materials and Methods: Rabies is a devastating disease worldwide caused by rabies virus. Proper usage of pre- or post-exposure rabies vaccine can prevent the disease transmission. In this study, mice were immunized with Vero cell-adapted inactivated rabies vaccine. RFFIT was used as a test to determine the serum neutralizing titers in infected/vaccinated mice. Seroprofiling of mice sera was done in vitro by ELISA. Results: Twenty-one days post-immunization, both ELISA and RFFIT assays indicated similar antibody levels in mice sera that were immunized with Vero cell-adapted inactivated rabies vaccine. Both the tests were correlated, and the linearity was verified by the regression line (R²=0.979). Conclusion: In this study, we profiled the serological status of Vero cell-adapted inactivated rabies vaccine through ELISA in mice model that correlated well with the OIE gold standard test RFFIT.
Collapse
Affiliation(s)
- Ashis Debnath
- Recombinant DNA Laboratory, Division of Veterinary Biotechnology, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - Dinesh C Pathak
- Recombinant DNA Laboratory, Division of Veterinary Biotechnology, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - Narayan Ramamurthy
- Recombinant DNA Laboratory, Division of Veterinary Biotechnology, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - Gulam Mohd
- Division of Biological Standardization, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - A B Pandey
- Division of Biological Standardization, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - Vikramaditya Upmanyu
- Division of Biological Standardization, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - A K Tiwari
- Division of Biological Standardization, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - R Saravanan
- Immunology Section, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - Madhan Mohan Chellappa
- Recombinant DNA Laboratory, Division of Veterinary Biotechnology, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| | - Sohini Dey
- Recombinant DNA Laboratory, Division of Veterinary Biotechnology, Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, India
| |
Collapse
|
26
|
Papatheodorou DP, Tasioudi KE, Korou LM, Georgiou V, Iliadou P, Markantonatos G, Kirtzalidou A, Tzani M, Chondrokouki E, Mangana-Vougiouka O. First four Oral Rabies Vaccination campaigns of the red foxes in Greece: Evaluating factors and assessment. Vet Microbiol 2018. [PMID: 29519504 DOI: 10.1016/j.vetmic.2018.01.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Following the last animal rabies outbreak in Greece in 2012, Oral Rabies Vaccination (ORV) campaigns of red foxes (Vulpes vulpes) were conducted in order to halt the spread of the disease, as widely and effectively have also been implemented in other countries. The present study aims to report the main outcomes following the first Greek ORV campaigns during autumn 2013, 2014, 2015 and spring 2016, to assess their effectiveness and to investigate factors potentially related to their success. Blood samples, mandible bones and teeth, derived by 452 foxes, were tested for rabies antibody titration, animal age determination and tetracycline (TTC) detection. The laboratory results obtained were statistically analyzed. High seroprevalence and TTC detection rates were obtained following the autumn campaigns studied, while these rates were significantly reduced following the spring campaign. The year or the season of the vaccination campaign, the estimated age group of the animal and the geographical Regional Unit (RU), where the animal was hunted, were identified as important factors. On the contrary, no significance could be ascertained for TTC detection based on exclusively previous uptake, use of filter paper, blood sample type and quality, as well as sex of animal. Based on the monitoring results achieved, the first ORV campaigns conducted in the country can be generally considered to be satisfactory. No positives cases were detected since May 2014. Seasonal, geographical parameters and factors related to fox ecology may interfere with monitoring results and should be always considered when planning future ORV programs.
Collapse
Affiliation(s)
- Dimos P Papatheodorou
- Virology Laboratory-National Reference Laboratory for Rabies in Animals, Department of Molecular Diagnostics, FMD, Virological, Rickettsial & Exotic Diseases, Directorate of Veterinary Center of Athens, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece.
| | - Konstantia E Tasioudi
- Virology Laboratory-National Reference Laboratory for Rabies in Animals, Department of Molecular Diagnostics, FMD, Virological, Rickettsial & Exotic Diseases, Directorate of Veterinary Center of Athens, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece
| | - Laskarina-Maria Korou
- Department of Zoonoses, Animal Health Directorate, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece
| | | | - Peristera Iliadou
- Virology Laboratory-National Reference Laboratory for Rabies in Animals, Department of Molecular Diagnostics, FMD, Virological, Rickettsial & Exotic Diseases, Directorate of Veterinary Center of Athens, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece
| | - Gerasimos Markantonatos
- Virology Laboratory-National Reference Laboratory for Rabies in Animals, Department of Molecular Diagnostics, FMD, Virological, Rickettsial & Exotic Diseases, Directorate of Veterinary Center of Athens, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece
| | - Aikaterini Kirtzalidou
- Virology Laboratory-National Reference Laboratory for Rabies in Animals, Department of Molecular Diagnostics, FMD, Virological, Rickettsial & Exotic Diseases, Directorate of Veterinary Center of Athens, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece
| | - Myrsini Tzani
- Department of Zoonoses, Animal Health Directorate, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece
| | - Eleni Chondrokouki
- Virology Laboratory-National Reference Laboratory for Rabies in Animals, Department of Molecular Diagnostics, FMD, Virological, Rickettsial & Exotic Diseases, Directorate of Veterinary Center of Athens, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece
| | - Olga Mangana-Vougiouka
- Virology Laboratory-National Reference Laboratory for Rabies in Animals, Department of Molecular Diagnostics, FMD, Virological, Rickettsial & Exotic Diseases, Directorate of Veterinary Center of Athens, Directorate General of Veterinary Services, Ministry of Rural Development and Food, Athens, Greece
| |
Collapse
|
27
|
Singh R, Singh KP, Cherian S, Saminathan M, Kapoor S, Manjunatha Reddy GB, Panda S, Dhama K. Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review. Vet Q 2017. [PMID: 28643547 DOI: 10.1080/01652176.2017.1343516] [Citation(s) in RCA: 110] [Impact Index Per Article: 15.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Rabies is a zoonotic, fatal and progressive neurological infection caused by rabies virus of the genus Lyssavirus and family Rhabdoviridae. It affects all warm-blooded animals and the disease is prevalent throughout the world and endemic in many countries except in Islands like Australia and Antarctica. Over 60,000 peoples die every year due to rabies, while approximately 15 million people receive rabies post-exposure prophylaxis (PEP) annually. Bite of rabid animals and saliva of infected host are mainly responsible for transmission and wildlife like raccoons, skunks, bats and foxes are main reservoirs for rabies. The incubation period is highly variable from 2 weeks to 6 years (avg. 2-3 months). Though severe neurologic signs and fatal outcome, neuropathological lesions are relatively mild. Rabies virus exploits various mechanisms to evade the host immune responses. Being a major zoonosis, precise and rapid diagnosis is important for early treatment and effective prevention and control measures. Traditional rapid Seller's staining and histopathological methods are still in use for diagnosis of rabies. Direct immunofluoroscent test (dFAT) is gold standard test and most commonly recommended for diagnosis of rabies in fresh brain tissues of dogs by both OIE and WHO. Mouse inoculation test (MIT) and polymerase chain reaction (PCR) are superior and used for routine diagnosis. Vaccination with live attenuated or inactivated viruses, DNA and recombinant vaccines can be done in endemic areas. This review describes in detail about epidemiology, transmission, pathogenesis, advances in diagnosis, vaccination and therapeutic approaches along with appropriate prevention and control strategies.
Collapse
Affiliation(s)
- Rajendra Singh
- a Division of Pathology , ICAR-Indian Veterinary Research Institute , Bareilly , Uttar Pradesh , India
| | - Karam Pal Singh
- b Centre for Animal Disease Research and Diagnosis (CADRAD) , ICAR-Indian Veterinary Research Institute , Bareilly , Uttar Pradesh , India
| | - Susan Cherian
- a Division of Pathology , ICAR-Indian Veterinary Research Institute , Bareilly , Uttar Pradesh , India
| | - Mani Saminathan
- a Division of Pathology , ICAR-Indian Veterinary Research Institute , Bareilly , Uttar Pradesh , India
| | - Sanjay Kapoor
- c Department of Veterinary Microbiology , LLR University of Veterinary and Animal Sciences , Hisar , Haryana , India
| | - G B Manjunatha Reddy
- d ICAR-National Institute of Veterinary Epidemiology and Disease Informatics , Bengaluru , Karnataka , India
| | - Shibani Panda
- a Division of Pathology , ICAR-Indian Veterinary Research Institute , Bareilly , Uttar Pradesh , India
| | - Kuldeep Dhama
- a Division of Pathology , ICAR-Indian Veterinary Research Institute , Bareilly , Uttar Pradesh , India
| |
Collapse
|
28
|
Efficacy of the oral rabies virus vaccine strain SPBN GASGAS in foxes and raccoon dogs. Vaccine 2017; 37:4750-4757. [PMID: 29042202 DOI: 10.1016/j.vaccine.2017.09.093] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2017] [Revised: 09/19/2017] [Accepted: 09/20/2017] [Indexed: 11/21/2022]
Abstract
To test the immunogenicity and efficacy of a new oral rabies virus vaccine strain SPBN GASGAS in wildlife target species, one group of foxes and two groups of raccoon dogs were offered a bait containing 1.7 ml of the vaccine (106.6 FFU/ml; 106.8 FFU/dose) and subsequently challenged approximately 180 days later with a fox rabies virus isolate. One group of raccoon dogs (n=30) received the same challenge dose (100.7 MICLD50/ml) as the red foxes (n=29). The other group with raccoon dogs (n=28) together with 8 animals that received the vaccine dose by direct instillation into the oral cavity (DIOC) were infected with a 40-fold higher dose of the challenge virus (102.3 MICLD50/ml). All but one of the 29 vaccinated foxes survived the challenge infection; meanwhile all 12 control foxes succumbed to rabies. Twenty-eight of 30 vaccinated raccoon dogs challenged with the same dose survived the infection, however only six of 12 control animals succumbed. When the higher challenge dose was administered, all 12 control animals died from rabies and all 36 vaccinated animals (28 baited plus 8 DIOC) survived. Blood samples were collected at different time points post vaccination and examined by both RFFIT and ELISA. The kinetics of the measured immune response was similar for both species, although in RFFIT slightly higher values were observed in foxes than in raccoon dogs. However, the immune response as measured in ELISA was identical for both species. The oral rabies virus vaccine SPBN GASGAS meets the efficacy requirements for live rabies virus vaccines as laid down by the European Pharmacopoeia.
Collapse
|
29
|
Wirblich C, Coleman CM, Kurup D, Abraham TS, Bernbaum JG, Jahrling PB, Hensley LE, Johnson RF, Frieman MB, Schnell MJ. One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus. J Virol 2017; 91:e02040-16. [PMID: 27807241 PMCID: PMC5215356 DOI: 10.1128/jvi.02040-16] [Citation(s) in RCA: 61] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Accepted: 10/30/2016] [Indexed: 12/16/2022] Open
Abstract
Middle East respiratory syndrome coronavirus (MERS-CoV) emerged in 2012 and is a highly pathogenic respiratory virus. There are no treatment options against MERS-CoV for humans or animals, and there are no large-scale clinical trials for therapies against MERS-CoV. To address this need, we developed an inactivated rabies virus (RABV) that contains the MERS-CoV spike (S) protein expressed on its surface. Our initial recombinant vaccine, BNSP333-S, expresses a full-length wild-type MERS-CoV S protein; however, it showed significantly reduced viral titers compared to those of the parental RABV strain and only low-level incorporation of full-length MERS-CoV S into RABV particles. Therefore, we developed a RABV-MERS vector that contained the MERS-CoV S1 domain of the MERS-CoV S protein fused to the RABV G protein C terminus (BNSP333-S1). BNSP333-S1 grew to titers similar to those of the parental vaccine vector BNSP333, and the RABV G-MERS-CoV S1 fusion protein was efficiently expressed and incorporated into RABV particles. When we vaccinated mice, chemically inactivated BNSP333-S1 induced high-titer neutralizing antibodies. Next, we challenged both vaccinated mice and control mice with MERS-CoV after adenovirus transduction of the human dipeptidyl peptidase 4 (hDPP4) receptor and then analyzed the ability of mice to control MERS-CoV infection. Our results demonstrated that vaccinated mice were fully protected from the MERS-CoV challenge, as indicated by the significantly lower MERS-CoV titers and MERS-CoV and mRNA levels in challenged mice than those in unvaccinated controls. These data establish that an inactivated RABV-MERS S-based vaccine may be effective for use in animals and humans in areas where MERS-CoV is endemic. IMPORTANCE Rabies virus-based vectors have been proven to be efficient dual vaccines against rabies and emergent infectious diseases such as Ebola virus. Here we show that inactivated rabies virus particles containing the MERS-CoV S1 protein induce potent immune responses against MERS-CoV and RABV. This novel vaccine is easy to produce and may be useful to protect target animals, such as camels, as well as humans from deadly MERS-CoV and RABV infections. Our results indicate that this vaccine approach can prevent disease, and the RABV-based vaccine platform may be a valuable tool for timely vaccine development against emerging infectious diseases.
Collapse
Affiliation(s)
- Christoph Wirblich
- Department of Microbiology and Immunology, Sydney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Christopher M Coleman
- Department of Microbiology and Immunology, University of Maryland at Baltimore, Baltimore, Maryland, USA
| | - Drishya Kurup
- Department of Microbiology and Immunology, Sydney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Tara S Abraham
- Department of Microbiology and Immunology, Sydney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - John G Bernbaum
- Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Maryland, USA
| | - Peter B Jahrling
- Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Maryland, USA
- Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Maryland, USA
| | - Lisa E Hensley
- Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Maryland, USA
| | - Reed F Johnson
- Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Fort Detrick, Maryland, USA
| | - Matthew B Frieman
- Department of Microbiology and Immunology, University of Maryland at Baltimore, Baltimore, Maryland, USA
| | - Matthias J Schnell
- Department of Microbiology and Immunology, Sydney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA
- Jefferson Vaccine Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| |
Collapse
|
30
|
Manalo DL, Yamada K, Watanabe I, Miranda MEG, Lapiz SMD, Tapdasan E, Petspophonsakul W, Inoue S, Khawplod P, Nishizono A. A Comparative Study of the RAPINA and the Virus-Neutralizing Test (RFFIT) for the Estimation of Antirabies-Neutralizing Antibody Levels in Dog Samples. Zoonoses Public Health 2016; 64:355-362. [PMID: 27863040 DOI: 10.1111/zph.12313] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2015] [Indexed: 11/27/2022]
Abstract
The mass vaccination of dogs against rabies is a highly rational strategy for interrupting the natural transmission of urban rabies. According to the World Organization for Animal Health (OIE) and the World Health Organization (WHO), the immunization of at least 70% of the total dog population minimizes the risk of endemic rabies. Knowledge of the virus-neutralizing antibody (VNA) level against the rabies virus (RABV) is required to evaluate protective immunity and vaccine coverage of dogs in the field. The rapid focus fluorescent inhibition test (RFFIT) and the fluorescent antibody virus neutralization (FAVN) test are recommended by OIE and WHO to determine the VNA levels in serum. However, these tests are cell culture based and require the use of live viruses and specialized equipment. The rapid neutralizing antibody test (RAPINA) is a novel, immunochromatographic test that uses inactivated virus to estimate the VNA level qualitatively. It is a simple, rapid and inexpensive, although indirect, assay for the detection of VNA levels. The RAPINA has shown good positive and negative predictive values and a high concordance with the RFFIT results. In this study, we compared the performance of the two tests for evaluating the vaccination status of dogs in the Philippines, Thailand and Japan. A total of 1135 dog sera were analysed by the RAPINA and compared to the VNA levels determined by the RFFIT. The overall positive and negative predictive values of the RAPINA were 96.2-99.3% and 84.5-94.8%, respectively, with a concordance (kappa) of 0.946-0.97 among the three countries. The RAPINA results were highly homologous and reproducible among different laboratories. These results suggest that this test is appropriate to survey vaccination coverage in countries with limited resources.
Collapse
Affiliation(s)
- D L Manalo
- Department of Health, Research Institute for Tropical Medicine (RITM-DOH), Alabang, Philippines
| | - K Yamada
- Research Promotion Institute, Faculty of Medicine, Oita University, Hasama-machi, Yufu City, Oita, Japan
| | - I Watanabe
- Department of Microbiology, Faculty of Medicine, Oita University, Hasama-machi, Yufu City, Oita, Japan
| | - M E G Miranda
- Department of Health, Research Institute for Tropical Medicine (RITM-DOH), Alabang, Philippines
| | - S M D Lapiz
- Office of the Provincial Veterinarian, Tagbilaran, Bohol, Philippines
| | - E Tapdasan
- Office of the Provincial Veterinarian, Tagbilaran, Bohol, Philippines
| | - W Petspophonsakul
- Department of Microbiology, Faculty of Medicine, Chiang Mai University, Lanna Dog Welfare, Chiang Mai, Thailand
| | - S Inoue
- Department of Veterinary Medicine, National Institute of Infectious Diseases, Tokyo, Japan
| | - P Khawplod
- Queen Saovabha Memorial Institute, Thai Red Cross Society, Bangkok, Thailand
| | - A Nishizono
- Department of Microbiology, Faculty of Medicine, Oita University, Hasama-machi, Yufu City, Oita, Japan
| |
Collapse
|
31
|
Wasniewski M, Almeida I, Baur A, Bedekovic T, Boncea D, Chaves LB, David D, De Benedictis P, Dobrostana M, Giraud P, Hostnik P, Jaceviciene I, Kenklies S, König M, Mähar K, Mojzis M, Moore S, Mrenoski S, Müller T, Ngoepe E, Nishimura M, Nokireki T, Pejovic N, Smreczak M, Strandbygaard B, Wodak E, Cliquet F. First international collaborative study to evaluate rabies antibody detection method for use in monitoring the effectiveness of oral vaccination programmes in fox and raccoon dog in Europe. J Virol Methods 2016; 238:77-85. [PMID: 27751949 DOI: 10.1016/j.jviromet.2016.10.006] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2016] [Revised: 10/06/2016] [Accepted: 10/13/2016] [Indexed: 10/20/2022]
Abstract
The most effective and sustainable method to control and eliminate rabies in wildlife is the oral rabies vaccination (ORV) of target species, namely foxes and raccoon dogs in Europe. According to WHO and OIE, the effectiveness of oral vaccination campaigns should be regularly assessed via disease surveillance and ORV antibody monitoring. Rabies antibodies are generally screened for in field animal cadavers, whose body fluids are often of poor quality. Therefore, the use of alternative methods such as the enzyme-linked immunosorbent assay (ELISA) has been proposed to improve reliability of serological results obtained on wildlife samples. We undertook an international collaborative study to determine if the commercial BioPro ELISA Rabies Ab kit is a reliable and reproducible tool for rabies serological testing. Our results reveal that the overall specificity evaluated on naive samples reached 96.7%, and the coefficients of concordance obtained for fox and raccoon dog samples were 97.2% and 97.5%, respectively. The overall agreement values obtained for the four marketed oral vaccines used in Europe were all equal to or greater than 95%. The coefficients of concordance obtained by laboratories ranged from 87.2% to 100%. The results of this collaborative study show good robustness and reproducibility of the BioPro ELISA Rabies Ab kit.
Collapse
Affiliation(s)
- M Wasniewski
- ANSES - Nancy Laboratory for Rabies and Wildlife, Technopôle Agricole et Vétérinaire, CS 40009, 54220 Malzéville, France.
| | - I Almeida
- Laboratório Nacional de Investigação Veterinária (LNIV), Estrada de Benfica No 701, 1549-011 Lisboa, Portugal
| | - A Baur
- Vet Med Labor GmbH, Division of IDEXX Laboratories, Mörikestr. 28/3, 71636 Ludwigsburg, Germany
| | - T Bedekovic
- Croatian Veterinary Institute Laboratory for Rabies/Virology, Savska cesta 143, Zagreb 10000, Croatia
| | - D Boncea
- Institute for Diagnosis and Animal Health, NRL For Rabies, no 63, Dr. Staicovici Street, sector 5 050557 Bucharest, Romania
| | - L B Chaves
- Laboratório de Diagnóstico da Raiva, Instituto Pasteur - Secretaria de Estado da Saúde de São Paulo, Avenida Paulista, 393 - Cerqueira César, São Paulo/SP 01311-000, Brazil
| | - D David
- Kimron Veterinary Institute Rabies Laboratory, Derech Hamacabim street, Bet Dagan 50250, Israel
| | - P De Benedictis
- Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell'Università 10, 35020 Legnaro, Padova, Italy
| | - M Dobrostana
- Institute of Food Safety, Animal Health and Environment "BIOR" Animal Diseases Diagnostic Laboratory, Lejupes iela 3, LV-1076 Riga, Latvia
| | - P Giraud
- Laboratoire Départemental d'Analyses du Pas-de-Calais, Parc de Hautes technologies des Bonnettes 2, rue du genévrier, 62022 Arras cedex 2, France
| | - P Hostnik
- National Veterinary Institute, Laboratory for Virology, Gerbiceva 60, 1 000 Ljubljana, Slovenia
| | - I Jaceviciene
- National Food and Veterinary Risk Assessment Institute, Virology Unit, Kairiukscio Str. 10, LT-08409 Vilnius, Lithuania
| | - S Kenklies
- Landesamt für Verbraucherschutz Sachsen-Anhalt, Fachbereich Veterinärmedizin, Haferbreiter Weg 132-135, 39576 Stendal, Germany
| | - M König
- Institute of Virology, Faculty of Veterinary Medicine, JLU-Giessen, Schubertstr. 81, 35392 Giessen, Germany
| | - K Mähar
- Estonian Veterinary and Food Laboratory, Virology and Serology Department, Kreutzwaldi 30, 51 006 Tartu, Estonia
| | - M Mojzis
- State Veterinary Institute Zvolen, Pod drahami 918, 960 86 Zvolen, Slovakia
| | - S Moore
- Kansas State University Rabies Laboratory, 2005 Research Park Circle, Manhattan, KS 66502, USA
| | - S Mrenoski
- University Ss Cyril and Methodius in Skopje, Faculty of Veterinary Medicine in Skopje, Department for Microbiology and Immunology, Lazar Pop Trajkov 5-7, 1000 Skopje, Republic of Macedonia
| | - T Müller
- Institute of Molecular Biology, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Südufer 10, 17493 Greifswald - Insel Riems, Germany
| | - E Ngoepe
- Agricultural Research Council-Onderstepoort Veterinary Institute (ARC-OVI), 100 old Soutpan road, Onderstepoort 0110 Pretoria, South Africa
| | - M Nishimura
- Research Institute for Animal Science In Biochemistry and Toxicology, 3-7-11, Hashimotodai, Midori-ku, Sagamihara-Kanagawa 252-0132, Japan
| | - T Nokireki
- Finnish Food Safety Authority, Evira Department Veterinary Virology, Mustialankatu, 3 00790 Helsinki, Finland
| | - N Pejovic
- Diagnostic Veterinary Laboratory - Podgorica Bul. Dzordza Vasingtona, bb p.fah 69, 81000 Podgorica, Montenegro
| | - M Smreczak
- National Veterinary Research Institute, Department of Virology, Partyzanow av. 57, 24-100 Pulawy, Poland
| | - B Strandbygaard
- DTU, National Veterinary Institute Division of Virology, Lindholm Kalvehave Havnevej 51 DK- 4771 Kalvehave, Denmark
| | - E Wodak
- AGES, Institute for Veterinary Disease Control Mödling, Department for Virology Robert Koch Gasse 17 A-2340 Mödling, Austria
| | - F Cliquet
- ANSES - Nancy Laboratory for Rabies and Wildlife, Technopôle Agricole et Vétérinaire, CS 40009, 54220 Malzéville, France
| |
Collapse
|
32
|
Korimbocus J, Dehay N, Tordo N, Cano F, Morgeaux S. Development and validation of a quantitative competitive ELISA for potency testing of equine anti rabies sera with other potential use. Vaccine 2016; 34:3310-6. [DOI: 10.1016/j.vaccine.2016.04.086] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2016] [Revised: 04/11/2016] [Accepted: 04/15/2016] [Indexed: 11/28/2022]
|
33
|
Bedeković T, Šimić I, Krešić N, Lojkić I, Mihaljević Ž, Sučec I, Janković IL, Hostnik P. Evaluation of ELISA for the detection of rabies virus antibodies from the thoracic liquid and muscle extract samples in the monitoring of fox oral vaccination campaigns. BMC Vet Res 2016; 12:76. [PMID: 27164987 PMCID: PMC4862130 DOI: 10.1186/s12917-016-0701-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2015] [Accepted: 05/04/2016] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The main goal of oral vaccination of foxes is eradication of rabies in the red fox population as rabies reservoirs. To evaluate the success of vaccination a serological testing is conducted as a part of monitoring program. Two different methods are used regarding rabies serology: virus neutralisation test and ELISA. METHODS In this study the reliability of BioPro ELISA was evaluated for testing haemolytic thoracic liquids and muscle extracts originated from 147 foxes in comparison to mFAVN. Also, the influence of heat treatment of samples on test results was investigated. RESULTS The specificity of the test for not-heat treated samples was 92.98% and sensitivity 79.20%. Diagnostic validity of the ELISA compared to the mFAVN test when not-heat treated samples were used was 89.16%. The specificity of the test for heat treated samples was 79.10% and sensitivity 96.36%. Diagnostic validity of the BioPro ELISA compared to the mFAVN test for heat treated samples was 94.30%. CONCLUSION According to this study, the BioPro ELISA is reliable tool for detection of rabies specific antibodies in the context of evaluation of oral vaccination of foxes from poor quality samples as a substitution for virus neutralisation tests.
Collapse
Affiliation(s)
- Tomislav Bedeković
- Croatian Veterinary Institute, Savska cesta 143, 10000, Zagreb, Croatia.
| | - Ivana Šimić
- Croatian Veterinary Institute, Savska cesta 143, 10000, Zagreb, Croatia
| | - Nina Krešić
- Croatian Veterinary Institute, Savska cesta 143, 10000, Zagreb, Croatia
| | - Ivana Lojkić
- Croatian Veterinary Institute, Savska cesta 143, 10000, Zagreb, Croatia
| | - Željko Mihaljević
- Croatian Veterinary Institute, Savska cesta 143, 10000, Zagreb, Croatia
| | - Ivica Sučec
- Veterinary Directorate, Planinska 2a, 10000, Zagreb, Croatia
| | | | - Peter Hostnik
- University of Ljubljana, Veterinary Faculty, Gerbičeva 60, 1115, Ljubljana, Slovenia
| |
Collapse
|
34
|
Robardet E, Picard-Meyer E, Dobroštana M, Jaceviciene I, Mähar K, Muižniece Z, Pridotkas G, Masiulis M, Niin E, Olševskis E, Cliquet F. Rabies in the Baltic States: Decoding a Process of Control and Elimination. PLoS Negl Trop Dis 2016; 10:e0004432. [PMID: 26849358 PMCID: PMC4743931 DOI: 10.1371/journal.pntd.0004432] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2015] [Accepted: 01/13/2016] [Indexed: 11/19/2022] Open
Abstract
Rabies is a fatal zoonosis that still causes nearly 70, 000 human deaths every year. In Europe, the oral rabies vaccination (ORV) of red foxes (Vulpes vulpes) was developed in the late 1970s and has demonstrated its effectiveness in the eradication of the disease in Western and some Central European countries. Following the accession of the three Baltic countries--Estonia, Latvia and Lithuania--to the European Union in 2004, subsequent financial support has allowed the implementation of regular ORV campaigns since 2005-2006. This paper reviews ten years of surveillance efforts and ORV campaigns in these countries resulting in the near eradication of the disease. The various factors that may have influenced the results of vaccination monitoring were assessed using generalized linear models (GLMs) on bait uptake and on herd immunity. As shown in previous studies, juveniles had lower bait uptake level than adults. For the first time, raccoon dogs (Nyctereutes procyonoides) were shown to have significantly lower bait uptake proportion compared with red foxes. This result suggests potentially altered ORV effectiveness in this invasive species compared to the red foxes. An extensive phylogenetic analysis demonstrated that the North-East European (NEE) rabies phylogroup is endemic in all three Baltic countries. Although successive oral vaccination campaigns have substantially reduced the number of detected rabies cases, sporadic detection of the C lineage (European part of Russian phylogroup) underlines the risk of reintroduction via westward spread from bordering countries. Vaccine induced cases were also reported for the first time in non-target species (Martes martes and Meles meles).
Collapse
Affiliation(s)
- Emmanuelle Robardet
- ANSES, Nancy Laboratory for Rabies and Wildlife, Bâtiment H, Technopôle Agricole et Vétérinaire, CS 40 009, Malzéville, France
| | - Evelyne Picard-Meyer
- ANSES, Nancy Laboratory for Rabies and Wildlife, Bâtiment H, Technopôle Agricole et Vétérinaire, CS 40 009, Malzéville, France
| | - Marianna Dobroštana
- BIOR, Institute of Food Safety, Animal Health and Environment "BIOR", Riga, Latvia
| | - Ingrida Jaceviciene
- National Food and Veterinary Risk Assessment Institute of Lithuania, Vilnius, Lithuania
- Vilniaus Kolegija/University of Applied Sciences Faculty of Agrotechnologies, Buivydiškės, Vilnius district, Lithuania
| | - Katrin Mähar
- Estonian Veterinary and Food Laboratory, Tartu, Estonia
| | - Zita Muižniece
- BIOR, Institute of Food Safety, Animal Health and Environment "BIOR", Riga, Latvia
| | - Gediminas Pridotkas
- National Food and Veterinary Risk Assessment Institute of Lithuania, Vilnius, Lithuania
| | | | - Enel Niin
- Estonian Veterinary and Food Board, Tallin, Estonia
| | - Edvīns Olševskis
- BIOR, Institute of Food Safety, Animal Health and Environment "BIOR", Riga, Latvia
- Food and Veterinary Service, Riga, Latvia
| | - Florence Cliquet
- ANSES, Nancy Laboratory for Rabies and Wildlife, Bâtiment H, Technopôle Agricole et Vétérinaire, CS 40 009, Malzéville, France
| |
Collapse
|
35
|
Rogier E, Wiegand R, Moss D, Priest J, Angov E, Dutta S, Journel I, Jean SE, Mace K, Chang M, Lemoine JF, Udhayakumar V, Barnwell JW. Multiple comparisons analysis of serological data from an area of low Plasmodium falciparum transmission. Malar J 2015; 14:436. [PMID: 26537125 PMCID: PMC4634594 DOI: 10.1186/s12936-015-0955-1] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2015] [Accepted: 10/21/2015] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND As a nation reduces the burden of falciparum malaria, identifying areas of transmission becomes increasingly difficult. Over the past decade, the field of utilizing malaria serological assays to measure exposure has grown rapidly, and a variety of serological methods for data acquisition and analysis of human IgG against falciparum antigens are available. Here, different immunoassays and statistical methods are utilized to analyse samples from a low transmission setting and directly compare the estimates generated. METHODS A subset of samples (n = 580) from a 2012 Haitian nationwide malaria survey was employed as sample population of low falciparum endemicity. In addition to the Haitian samples, samples from 247 US residents were used as a reference population of 'true seronegatives'. Data acquisition was performed through standard ELISA and bead-based multiplex assays assaying for IgG antibodies to the Plasmodium falciparum antigens MSP-1p19, MSP-1p42(D), MSP-1p42(F), and AMA-1. Appropriate parametric distributions and seropositivity cutoff values were determined by statistical measures. RESULTS Data from both assays showed a strong positive skew, and the lognormal distribution was found to be an appropriate statistical fit to the Haitian and American populations. The American samples served as a good serological true negative population for the multiplex assay, but not for ELISA-based data. Mixture model approaches to determine seronegative and seropositive populations from the Haitian data showed a high degree of distribution overlap-likely due to the historical low falciparum transmission in this nation. Different fittings to the reversible catalytic model resulted depending upon the immunoassay utilized and seropositivity cutoff method employed. Data were also analysed through fitting to penalized B-splines, presenting another possible analytical tool for the analysis of malaria serological data. CONCLUSIONS Standardization of serological techniques and analyses may prove difficult as some tools can prove to be more useful depending on the area and parasite in question, making clear interpretation a vital pursuit. The presented analysis in the low-endemic nation of Haiti found malaria-naive US residents to be an appropriate seronegative reference population for the multiplex assay, and this assay providing consistent estimates between MSP-1 and AMA-1 antigens of percent seropositives for this low-endemic population.
Collapse
Affiliation(s)
- Eric Rogier
- Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, USA.
| | - Ryan Wiegand
- Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, USA.
| | - Delynn Moss
- Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, USA.
| | - Jeff Priest
- Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, USA.
| | - Evelina Angov
- Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
| | - Sheetij Dutta
- Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
| | - Ito Journel
- Laboratoire National de Santé Publique (LNSP)/Ministère de la Santé Publique et de la Population (MSPP), Port-au-Prince, Haiti.
| | - Samuel E Jean
- Population Services International/Organisation Haïtienne de Marketing Social pour la Santé, Port-au-Prince, Haiti.
| | - Kimberly Mace
- Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, USA.
| | - Michelle Chang
- Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, USA.
| | | | - Venkatachalam Udhayakumar
- Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, USA.
| | - John W Barnwell
- Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Center for Global Health, Atlanta, GA, USA.
| |
Collapse
|
36
|
Lupulovic D, Maksimovic Zoric J, Vaskovic N, Bugarski D, Plavsic B, Ivanovic N, Petrovic T, Pusic I, Marcic D, Grgic Z, Lazic S. First Report on the Efficiency of Oral Vaccination of Foxes against Rabies in Serbia. Zoonoses Public Health 2015; 62:625-36. [DOI: 10.1111/zph.12196] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2014] [Indexed: 12/29/2022]
Affiliation(s)
- D. Lupulovic
- Scientific Veterinary Institute ‘Novi Sad’; Novi Sad Serbia
| | | | - N. Vaskovic
- Veterinary Institute ‘Kraljevo’; Kraljevo Serbia
| | - D. Bugarski
- Veterinary Directorate, Ministry of Agriculture and Environmental Protection; Belgrade Serbia
| | - B. Plavsic
- Veterinary Directorate, Ministry of Agriculture and Environmental Protection; Belgrade Serbia
| | | | - T. Petrovic
- Scientific Veterinary Institute ‘Novi Sad’; Novi Sad Serbia
| | - I. Pusic
- Scientific Veterinary Institute ‘Novi Sad’; Novi Sad Serbia
| | - D. Marcic
- Scientific Veterinary Institute ‘Novi Sad’; Novi Sad Serbia
| | - Z. Grgic
- Scientific Veterinary Institute ‘Novi Sad’; Novi Sad Serbia
| | - S. Lazic
- Scientific Veterinary Institute ‘Novi Sad’; Novi Sad Serbia
| |
Collapse
|
37
|
Use of filter paper blood samples for rabies antibody detection in foxes and raccoon dogs. J Virol Methods 2014; 204:11-6. [PMID: 24731929 DOI: 10.1016/j.jviromet.2014.04.005] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2014] [Revised: 04/01/2014] [Accepted: 04/04/2014] [Indexed: 12/24/2022]
Abstract
The effectiveness of oral rabies vaccination in wildlife is usually evaluated by the detection of rabies antibodies. However, the assessment of rabies antibodies has several technical difficulties in the field, such as the collection, storage, transport and titration of blood samples, often of poor quality. The objective of this study was to assess the feasibility of collecting blood on a filter paper (FP) coupled with enzyme-linked immunosorbent assay (ELISA) titration of rabies antibodies in raccoon dogs and red foxes. The FP blood sampling method was found highly specific and repeatable in both species. Overall, results obtained with the FP sampling method were highly concordant with the conventional (venipuncture) sampling methods. Blood eluates from FP samples from foxes and raccoon dogs tested using ELISA showed concordance values of 92% and 95%, respectively, with serum samples tested using the seroneutralisation test and values of 95% and 91%, respectively, when the ELISA was used on both types of sample. The use of FP blood sampling coupled with the titration of rabies antibodies by ELISA provides a reliable alternative to conventional blood sampling and serum testing by seroneutralisation. This simple procedure is particularly attractive and cost-effective for assessing the effectiveness of oral rabies vaccination in field conditions.
Collapse
|
38
|
Hendricks CG, Levy JK, Tucker SJ, Olmstead SM, Crawford PC, Dubovi EJ, Hanlon CA. Tail vaccination in cats: a pilot study. J Feline Med Surg 2014; 16:275-80. [PMID: 24108201 PMCID: PMC11383107 DOI: 10.1177/1098612x13505579] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Feline injection site sarcomas affect 1-10 cats per every 10,000 vaccinated and are associated with high mortality. Radical resection may be curative, but is often associated with prolonged recovery, disfigurement and loss of function when tumors occur at currently recommended injection sites. The objective of this study was to assess alternatives to currently recommended vaccination sites in terms of preference by oncology practitioners, ease of injection and serological responses. Surgical, radiation and medical oncology practitioners were surveyed regarding their preference for vaccination sites based on the ease of tumor resection. A six-point Likert scale was used to measure each cat's behavioral reaction to vaccination when injected subcutaneously in the distal hind limb or the distal tail. Serum collected before and 1-2 months after vaccination was tested for antibody titers against feline panleukopenia virus (FPV) and rabies virus (RV). The preferred sites for vaccination by 94 oncology practitioners were below the stifle (41%) and the tail (30%). There were no significant differences in the cats' behavioral reaction to vaccination below the stifle (n = 31) and in the distal tail (n = 29). Of the cats seronegative for FPV at the time of vaccination, 100% developed protective antibody titers (≥40) against FPV 1-2 months following vaccination. For cats seronegative for RV, all but one cat (tail vaccine) developed acceptable antibody titers (≥0.5 IU/ml) against RV. Tail vaccination was well tolerated and elicited similar serological responses to vaccination in the distal limbs.
Collapse
Affiliation(s)
- Cleon G Hendricks
- 1Maddie's Shelter Medicine Program, Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA
| | | | | | | | | | | | | |
Collapse
|
39
|
Wasniewski M, Labbe A, Tribout L, Rieder J, Labadie A, Schereffer JL, Cliquet F. Evaluation of a rabies ELISA as an alternative method to seroneutralisation tests in the context of international trade of domestic carnivores. J Virol Methods 2013; 195:211-20. [PMID: 24161815 DOI: 10.1016/j.jviromet.2013.10.021] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2013] [Revised: 10/07/2013] [Accepted: 10/11/2013] [Indexed: 11/18/2022]
Abstract
For several years, international movements with pets have greatly increased. Most countries have relaxed their quarantine measures and adopted a scheme combining vaccination of pets against rabies followed by a serological test to check the efficacy of vaccination. This new scheme has been strongly supported by the OIE, WHO and the European Commission to facilitate the free movement of people and pets around the world. Currently, only two reference methods are recognised and prescribed (the FAVN test and the RFFIT) to measure rabies antibody levels in serum samples for international trade. They are reliable and valuable methods of assessing the efficacy of rabies vaccination but they are time-consuming and require well-trained people and specialised laboratory facilities. A few years ago, an ELISA (Platelia™ Rabies II kit ad usum Veterinarium) was developed for domestic carnivores and wildlife. To our knowledge, this ELISA is the only one certified and prescribed by the OIE. Following its marketing, one task of the EURL for rabies serology was to evaluate the performance of laboratories using this new kit. The results revealed that 26% of the participants, which were already approved laboratories for rabies serology, failed the inter-laboratory trial. Such unsatisfactory results have never been observed during any of the previous proficiency tests organised annually since 2000 by the EURL for rabies serology using reference methods. More investigations were undertaken through internal and collaborative studies to assess the performance of this newly marketed ELISA kit. The results of the internal study revealed that even with a specificity of 100%, the sensitivity evaluated on 593 samples of domestic carnivores came to 78.2%. An issue regarding the underestimation of serum titres was also revealed during the study. The results of a collaborative study involving 23 international laboratories reinforced the preliminary conclusions regarding lack of sensitivity. Indeed, only 5 laboratories out of the 23 obtained satisfactory results. We therefore suggest adopting a threshold of 0.3 EU/mL instead of 0.5 EU/mL to increase the sensitivity of the test.
Collapse
Affiliation(s)
- M Wasniewski
- French Agency for Food, Environmental and Occupational Health & Safety (ANSES), Nancy Laboratory for Rabies and Wildlife, European Union Reference Laboratory for Rabies, European Union Reference Laboratory for Rabies Serology, WHO Collaborating centre for Research & Management in Zoonoses Control, OIE Reference Laboratory for Rabies, Technopôle agricole et vétérinaire, BP 40 009, 54 220 Malzéville Cedex, France
| | | | | | | | | | | | | |
Collapse
|
40
|
Bedeković T, Lemo N, Lojkić I, Mihaljević Z, Jungić A, Cvetnić Z, Cač Z, Hostnik P. Modification of the fluorescent antibody virus neutralisation test--elimination of the cytotoxic effect for the detection of rabies virus neutralising antibodies. J Virol Methods 2013; 189:204-8. [PMID: 23403247 DOI: 10.1016/j.jviromet.2013.01.022] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2012] [Revised: 01/25/2013] [Accepted: 01/30/2013] [Indexed: 10/27/2022]
Abstract
The virus neutralisation test is used for the quantitation of specific antibodies in serum samples. However, the success of the test depends on the quality of samples. In the case of poor quality samples, a cytotoxic effect can be observed and the results of the test can be compromised. Additionally, the cytotoxic effect limits the use of different substances, such as muscle extract or liquid from thoracic cavity (thoracic liquid), as a sample for the detection of rabies virus neutralising antibodies in the follow-up of fox oral vaccination campaigns. To eliminate the cytotoxic effect, a modified fluorescent antibody virus neutralisation (mFAVN) test was developed and evaluated. In the mFAVN test, inocula were removed after a 1h and the cytotoxic effect was prevented. According to the results obtained, the specificity of the mFAVN test compared to the FAVN test was 88.8% and the sensitivity was 94.4%. The diagnostic validity of the test was 0.99 (CI=0.98-1.00). To evaluate the possibility of using muscle extract and thoracic liquid as samples for the virus neutralisation test, 102 sera, muscle extract and thoracic liquid samples of dog origin were tested with the mFAVN test. The correlation between sera and muscle extracts was 87.9% (r=0.88, p<0.001). The correlation between sera and thoracic liquid was 94.2% (r=0.94, p<0.001). These findings indicated that both muscle extract and thoracic liquid could be used as samples for detection of rabies virus neutralising antibodies in the follow-up of oral vaccination campaigns. To evaluate the level of elimination of the cytotoxic effect, the 102 samples of sera, muscle extracts and thoracic liquid of dog origin were also tested in parallel using the mFAVN and FAVN tests. In the mFAVN test, no instance of cytotoxic effect was observed in the cells. In the FAVN test, two sera (1.9%), 35 muscle extracts (34.3%) and 56 thoracic liquid samples (54.9%) showed cytotoxic effect. The results of this study strongly suggest that cytotoxic effect can be eliminated completely from the rabies virus neutralising antibody detection tests used in the follow-up of oral vaccination campaigns and that very poor quality samples, such as muscle extract and thoracic liquid, can be used.
Collapse
|
41
|
Wasniewski M, Guiot A, Schereffer J, Tribout L, Mähar K, Cliquet F. Evaluation of an ELISA to detect rabies antibodies in orally vaccinated foxes and raccoon dogs sampled in the field. J Virol Methods 2013. [DOI: 10.1016/j.jviromet.2012.11.022] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|